PRN News Briefs

Promotions

Carrie Martin Blanchard: Research Assistant Professor, UNC Eshelman School of Pharmacy.

Krystal L. Edwards: Full Professor effective September 1, 2018.

S. Mimi Mukherjee: Associate Professor of Pharmacy Practice, MCPHS University –Worcester/Manchester.

Maria Miller Thurston: Clinical Associate Professor.

Daniel R. Touchette: Full Professor.

Autumn Zuckerman: Program Director of Health Outcomes and Research at Vanderbilt Specialty Pharmacy.

Awards

Laura Challen: Missouri Society of Health-System Pharmacists, Preceptor of the Year Award (May 2018).

Lucas Hill:
Pharmacy Association Generation Rx Champion Award.
UT School of Undergraduate Studies Distinguished University Lecturer.

Adriane Irwin: Distinguished Faculty Award for Excellence, Oregon Health & Science University, May 2018.

Shannon A. Miller: Teacher of the Year Award, UF College of Pharmacy.

Maria Miller Thurston: AACP Award for Excellence in Assessment.

Joyanna “Joy” Wright: DCPA Sidney Simkowicz Pharmacy Involvement Award.

Autumn Zuckerman:
Carl Wayne Shaddix Award Pharmacy Practitioner of Excellence Award, Samford University McWhorter School of Pharmacy.
National Association of Specialty Pharmacy 2017 Abstract Poster Award – Third Place; September 2017.

Grants

Lucas Hill: Principal Investigator: Texas Targeted Opioid Response Overdose Prevention Project. Texas Health & Human Services Commission ($2,587,149). 2017–2019.

Marissa Salvo: Co-Investigator in the grant “State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health-Pharmacy Initiative.” This 5-year grant was initially funded in 2013 by the Centers for Disease Control and Prevention through the Connecticut Department of Public Health; a 3-month extension (June 30 – September 29, 2018) of $20,000 was awarded to continue the project.

Publications

Ai A, Wong A, Amato M, Wright A. Communication failure: prescribers’ use of an internal free-text field on electronic prescriptions. J Am Med Inform Assoc 2018;25:709-14. First published online 21 February 2018.

Cheng CM, Salazar A, Amato M, Lambert BL, Volk L, Schiff G. Using drug knowledge base information to distinguish between commonly confused drugs. J Am Med Inform Assoc 2018. First published online May 22, 2018.

Kron K, Myers S, Volk L, Nathan A, Neri P, Salazar A, Amato MG, Wright A, Karmiy S, McCord S, Seoane-Vazquez E, Eguale T, Rodriguez-Monguio R, Bates DW, Schiff G. Incorporating medication indications into the prescribing process. Am J Health Syst Pharm 2018;75:774-83. Published ahead of print on April 19, 2018.

Wong A, Amato MG, Seger DL, Rehr CA, Wright A, Slight SP, Beeler PE, Orav EO, Bates DW. Prospective evaluation of medication-related clinical decision support overrides in the intensive care unit. BMJ Qual Saf. Published online ahead of print February 9, 2018.

Bagwell A, Kelley T, Carver A, Lee JB, Newman B. Advancing patient care through specialty pharmacy services in an academic health system. J Manag Care Spec Pharm 2017;23:815-20.

Hill L. Harm reduction approaches to opioids. In: Schepis TS, ed. The Prescription Drug Abuse Epidemic: Incidence, Prevention, Treatment, and Policy. Santa Barbara, CA: ABC-CLIO, 2018:227-41.

Herink MC, Irwin AN, Zumach GM. FDA breakthrough therapy designation: evaluating the evidence behind the approvals. Pharmacotherapy 2018. [Epub ahead of print]

Jobin J, Irwin AN, Pimentel J, Tanner M. Accuracy of medication histories collected by pharmacy technicians during hospital admission. Res Social Adm Pharm 2018;7:695-9.

Peck A, Irwin AN. Lessons learned from implementation of a “geriatric-friendly” admission order set. J Pharm Tech 2018;34:181-2.

Ling H*, Andrews E, Ombengi D, Li F. Extended duration dual antiplatelet therapy after percutaneous coronary intervention in patients with peripheral arterial disease: a meta-analysis. Cardiol Res 2018;9:137-43.

Plakogiannis R, Mola A, Sinha S, Oh H, Stefanidis A, Katz S. Impact of pharmacy student driven post discharge telephone calls on heart failure hospital readmission rates: a pilot program. Hosp Pharm April 2018.

Whalley AS, Salvo MC, Levine SF, Chamberlin KW, Beaudoin D. Evaluation of pharmacist involvement in outpatient transitions of care. J Gen Intern Med 2018. [Epub ahead of print]

Sigler MA, Congdon L, Edwards KL. An evidence-based review of statin use in patient with nonalcoholic fatty liver disease. Clin Med Insights Gastroenterol 2018;11:1179552218787502.

Eltaki S, Singh-Franco D, Leon D, Nguyen M, Wolowich WR. Allocation of faculty and curricular time to the teaching of transitions of care concepts by colleges of pharmacy. Curr Pharm Teach Learn 2018;10:701-11.

Joyner KR, Soric MM, Boyle JA, Moorman JM, Fredrickson ME, Turosky JZ, Kleven CL. Mineralocorticoid receptor antagonist utilization in a nationally representative heart failure with reduced ejection fraction outpatient population: a cross-sectional study. Am J Ther 2018. Published ahead of print.

Rattray DJ, Whitner Ver Vaet JB, Lisenby KM. Medication Reconciliation Guidance Document for Pharmacists. Available at https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/ambulatory-care/medication-reconciliation-guidance-document-for-pharmacists.ashx?la=en&hash=8E66CC1F528D577B650D3B19F4A2EE310E68A75B.

Bullock KC, Gibson C, Howard M, Liu J, Tatachar A, Yuet WC. Use of the muddiest point technique as an exam review in an integrated pharmacotherapy course. Curr Pharm Teach Learn 2018. In press.

Zuckerman A, Chastain CA, Naggie S. Retreatment options following HCV direct acting antiviral failure. Curr Treat Options Infect Dis 2017;9:389-402.

Zuckerman A, Douglas A, Nwosu S, Choi L, Chastain C. Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era. PLoS One 2018;13:e0199174.

Other Notable Achievements

Kyle Bertram: BCACP.

Hua Ling: Academic Editor, Medicine, an open access peer-reviewed medical journal published by Wolters Kluwer.

Roda Plakogiannis: Member Spotlight (page 30), Lipid Spin Publication of the National Lipid Association.

Edward Saito: PGY2 Ambulatory Care Residency Program Director, Pacific University/Virginia Garcia Memorial Health Center.

Joyanna “Joy” Wright: Running for FPA President-Elect.

Members of the Adult Medicine PRN have been advancing its initiatives by expanding its monthly pharmacy resident journal clubs to include student presentations and developing new criteria to support members for ACCP investigator training programs and seed grant funding. The PRN’s social media presence also continues to grow (Twitter: @accpamedprn; Facebook: www.facebook.com/accpamedprn) to help connect the PRN’s members and facilitate communication regarding research and evidence-based medicine. Adult Medicine PRN members have also persistently been advancing adult medicine pharmacotherapy through innovative patient care and research, as evidenced by the recent accomplishments noted in the text that follows.

Promotions

Jeremy Vandiver: Clinical Associate Professor, University of Wyoming School of Pharmacy.

Awards

Sarah L. Anderson: Denver Health Quality, Safety, and Service Team Award for improving safety and quality for anticoagulation patients, June 2018.

Jennifer Austin Szwak: Choosing Wisely Challenge Winner for “Nebs No More After 24” Initiative.

Alex Ebied: Pharmacy Recurring Opportunity Seed Program for Education and Research Award.

Caitlin Gibson: M.E.T. Award for Outstanding Junior Faculty Achievement from the University of North Texas System College of Pharmacy.

Aaron Hartmann: St. Louis College of Pharmacy Clinical Pharmacy Excellence Award.

Jordan L. Kelley: UK College of Pharmacy PGY1 Residency Scholarship for devotion to research and publishing.

Jeremy Vandiver: Colorado Pharmacists Society Distinguished Young Pharmacist 2018.

Grants

Jennifer Austin Szwak: University of Chicago Medicine Innovation Grant for “ACT VALUE Program for Asthma and COPD”; funding: $100,000.

Publications

Anderson SL, Marrs JC. Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment. Drugs Context 2018;7:212542.

Anderson SL, Marrs JC. The role of the pharmacist in heart failure transition of care. Adv Ther 2018;35:311-23.

Marrs JC, Anderson SL, Gabriel C. Role of aldosterone receptor antagonists in heart failure with preserved ejection fraction. Clin Med Insights Ther 2018;10:1-9.

Christenberry EJ, Padilla ME, Aguirre M, Loya AM, Aragon L. Reliability of point-of-care international normalized ratio testing in an academic family medicine clinic. Point Care 2018;17:55-8.

Sebaaly J, Covert K. Enoxaparin dosing at extremes of weight: literature review and dosing recommendations. Ann Pharmacother 2018;52:898-909.

D’Angelo RG, McGiness T, Waite LH. Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: where are we now? Ann Pharmacother 2018;52:884-97.

Ebied AM, Cooper-DeHoff RM. 2017 is banner year for drug approvals by the Food and Drug Administration. Am J Med 2018. [Epub ahead of print]

Ebied AM, Gracey S. Acetazolamide induced sickle cell crisis. Ann Pharmacother 2018. [Epub ahead of print]

Gibson CM, Basto AN, Howard ML. Direct oral anticoagulants in cardioversion: a review of current evidence. Ann Pharmacother 2018;52:277-84.

Gibson CM, Smith CB, Scalese M. Assessment of apixaban prescribing patterns for non-valvular atrial fibrillation in hospitalized patients. Ann Pharmacother 2018;52:54-9.

Kabakov A, Kolanczyk D. Book review of: Soric MM, Schneider SR, Wisneski SS. The Effective Pharmacy Preceptor. Bethesda, MD: American Society of Health-System Pharmacists, 2017.

Hawes EM, Lambert E, Reid A, Tong G, Gwynne M. Implementation and evaluation of a pharmacist-led electronic visit program for diabetes and anticoagulation care in a patient-centered medical home. Am J Health Syst Pharm 2018;75:901-10.

Moore DC, Arnall JR, Harvey RD. Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. J Oncol Pharm Pract 2018. [Epub ahead of print]

Moore DC, Lavery L. Olaratumab: a new strategy in the treatment of advanced soft-tissue sarcoma. J Adv Pract Oncol 2018;9:235-40.

Moore DC, Ringley JT. Rhabdomyolysis with abiraterone exposure: a review of the Food and Drug Administration Adverse Drug Event Reporting System. Ann Pharmacother 2018. [Epub ahead of print]

Patel J, Ringley JT, Moore DC. Case series of docetaxel-induced dorsal hand-foot syndrome. Ther Adv Drug Saf 2018;9:495-8.

Singhi E, Moore DC, Muslimani A. Metastatic soft tissue sarcoma: a review of treatment and new pharmacotherapies. P T 2018;43:410-5.

Borghol A, Aucoin M, Onor I, Jamero D, Hawawini F. Modafinil for the improvement of patient outcomes following traumatic brain injury. Innov Clin Neurosci 2018;15:17-23.

Onor IO, Stirling DL, Williams SR, Bediako D, Borghol A, Harris MB, Darensburg TB, Clay SD, Okpechi SC, Sarpong DF. Clinical effects of cigarette smoking: epidemiologic impact and review of pharmacotherapy options. Int J Environ Res Public Health 2017;14:1147.

Ezebuenyi MC, Brakta F, Onor IO, Sarpong DF, Burks KB, Figueroa JE. Evaluation of physician prescribing patterns for antibiotics in the treatment of nonnecrotizing skin and soft tissue infections. P T 2018;43:287-92.

Joyner KR, Soric MM, Boyle JA, Moorman JM, Fredrickson ME, Turosky JZ, Kleven CL. Mineralocorticoid receptor antagonist utilization in a nationally representative heart failure with reduced ejection fraction outpatient population: a cross-sectional study. Am J Ther 2018. [Epub ahead of print]

Hlavacek N, McMillan D, Vandiver J. Periprocedural management of oral anticoagulation: when and how to hit “pause.” J Fam Pract 2018;67:210, 216, 219, 222.

Vandiver JW, Beavers DK. Combining oral anticoagulation and antiplatelet therapies: appropriate patient selection. J Thromb Thrombolysis 2018;45:423-31.

New ACCP Fellows

Jennifer E. Stark

Other Notable Achievements

>Alex Ebied: Interview with CNN regarding the safety of breakthrough drugs. Available at https://www.cnn.com/2018/07/17/health/fda-breakthrough-drugs-study/index.html.

Angela Miller: Evaluation of a pharmacist discharge counseling process in pulmonary hypertension patients. Poster presented at: 2018 Pulmonary Hypertension Association International Pulmonary Hypertension Conference.

Promotions

Katherine E. Di Palo: Director, Hospital Readmissions Reduction Program, Montefiore Medical Center.

Ryan B. Jacobsen: Clinical Associate Professor, University of Iowa College of Pharmacy, Department of Pharmacy Practice and Science, Division of Applied Clinical Sciences.

Oksana Kamneva: Critical Care and Cardiology Pharmacy Manager, UNC REX Healthcare.

Amanda Morrill: Associate Professor of Pharmacy Practice, MCPHS University, School of Pharmacy – Worcester/Manchester.

Awards

James E. Tisdale (Principal Investigator): American Heart Association, Transformational Project Award: “Reducing the Risk of Drug-Induced QT Interval Lengthening in Women” (18TPA34170523). July 1, 2018 – June 30, 2021.

Benjamin Van Tassell
Principal Investigator: Single-Site Investigator-Initiated Clinical Trials. National Heart, Lung, and Blood Institute. “The Effects of Interleukin-1 Blockade On Exercise Capacity in Patients with Recently Decompensated Systolic Heart Failure” (1R61HL139943). July 1, 2018 – June 30, 2019.

Co-Investigator: Investigator-Initiated Research Proposal. Olatec Therapeutics LLC. A Phase 1b, Randomized, Double-Blinded, Dose Escalation, Single Center, Repeat-Dose Safety and Pharmacodynamics Study of Orally Administered Dapansutrile Capsules in Subjects with NYHA II-III Systolic Heart Failure. May 2018 – April 2019.

Publications

Bader F, Atallah B, Rizk J, et al. Heart transplantation in the Middle East gulf region. Transplantation 2018;102:1023-6.

Bader F, Atallah B, Sadik ZG, et al. Nurse-led education for heart failure patients in developing countries. Br J Nurs 2018;27:690-6.

Ather A, Laliberte B, Reed BN, Schenk A, Watson K, Devabhakthuni S, See V. Antithrombotic strategies for patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiovasc Drugs 2018 Jun 19. [Epub ahead of print]

Caranfa JT, Ali R, Francis I, Zichichi A, Bosco E, Baker WL, Coleman CI, Kohn CG. Mechanical endovascular therapy for acute ischemic stroke: an indirect treatment comparison between Solitaire and Penumbra thrombectomy devices. PLoS One 2018;13:e0191657.

Coleman CI, Turpie AGG, Bunz TJ, Baker WL, Beyer-Westendorf J. Effectiveness and safety of rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state. Thromb Res 2018;163:132-7.

Coleman CI, Turpie AGG, Bunz TJ, Eriksson D, Sood NA, Baker WL. Effectiveness and safety of rivaroxaban versus warfarin in nonvalvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1. Eur Heart J Cardiovasc Pharmacother 2018 Jul 17. [Epub ahead of print]

Kohn CG, Lyman GH, Beyer-Westendorf J, Spyropoulos AC, Bunz TJ, Baker WL, Eriksson D, Meinecke AK, Coleman CI. Effectiveness and safety of rivaroxaban in patients with cancer-associated venous thrombosis. J Natl Compr Canc Netw 2018;16:491-7.

Martinez BK, Sheth J, Patel N, Baker WL, Coleman CI. Systematic review and meta-analysis of real-world studies evaluating rivaroxaban for cancer-associated venous thrombosis. Pharmacotherapy 2018;38:610-8.

Patel N, Gluck JA, Radojevic J, Coleman CI, Baker WL. Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysis. ESC Heart Fail 2018 Jul 27. [Epub ahead of print]

Trexler S, Nguyen E, Baker WL. Electrocardiographic effects of Hawthorn (Crataegus oxyacantha) in healthy volunteers: a randomized controlled trial. Phytother Res 2018 Apr 19. [Epub ahead of print]

Buckley LF, Canada JM, Del Buono MG, Carbone S, Trankle CR, Billingsley H, Kadariya D, Arena R, Van Tassell BW, Abbate A. Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction. ESC Heart Fail 2018;5:372-8.

Buckley LF, Carbone S, Trankle CR, Canada JM, Erdle CO, Regan JA, Viscusi MM, Kadariya D, Billingsley H, Arena R, Abbate A, Van Tassell BW. Effect of interleukin-1 blockade on left ventricular systolic performance and work: a post hoc pooled analysis of 2 clinical trials. J Cardiovasc Pharmacol 2018;72:68-70.

Buckley LF, Dixon DL, Wohlford GF IV, Wijesinghe DS, Baker WL, Van Tassell BW. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: a subgroup analysis of high-risk ACCORDION trial participants. Diabetes Obes Metab 2018;20:1499-502.

Carbone S, Canada JM, Buckley LF, Trankle CR, Billingsley HE, Dixon DL, Mauro AG, Dessie S, Kadariya D, Mezzaroma E, Buzzetti R, Arena R, Van Tassell BW, Toldo S, Abbate A. Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction. JACC Basic Transl Sci 2017;2:513-25.

Coons JC, Miller T. Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience. Ther Adv Respir Dis 2018;12.

DiDomenico RJ. Residency application deadlines: can we all just agree on a date? Am J Health Syst Pharm 2018;75:849-50.

Gasbarro NM, DiDomenico RJ. Frequency of “on-label” use of intravenous diltiazem for rate control in patients with acute-onset atrial fibrillation or atrial flutter. Am J Health Syst Pharm 2018. In press.

Kim K, Lee TA, DiDomenico RJ, Ardati AK, Touchette DR, Walton SM. Comparison of six-month costs between oral antiplatelet agents following acute coronary syndrome. J Manag Care Spec Pharm 2018. In press.

Zueger PM, Kumar VM, Harrington R, Rigoni G, Atwood AM, DiDomenico RJ, Touchette DR. Cost-effectiveness analysis of sacubitril-valsartan for the treatment of heart failure with reduced ejection fraction in the United States. Pharmacotherapy 2018;38:520-30.

Di Palo KE, Kish T. The role of the pharmacist in hypertension management. Curr Opin Cardiol 2018;33:382-7.

Di Palo KE, Patel K, Kish T. Risk reduction to disease management: clinical pharmacists as cardiovascular care providers. Curr Probl Cardiol 2018.

Piña IL, Di Palo KE, Ventura HO. Psychopharmacology and cardiovascular disease. J Am Coll Cardiol 2018;71:2346-59.

Dixon DL, Salgado TM, Caldas LM, Van Tassell BW, Sisson EM. The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists. J Am Pharm Assoc (2003). 2018;58:382-6.

Carbone S, Canada JM, Billingsley HE, Kadariya D, Dixon DL, Trankle CR, Buckley LF, Markley R, Vo C, Medina de Chazal H, Christopher S, Buzzetti R, Van Tassell BW, Abbate A. Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics. Diabetes Obes Metab 2018;20:2014-8.

Bhat S, Kansal M, Kondos GT, Groo V. Outcomes of a pharmacist-managed heart failure medication titration assistance clinic. Ann Pharmacother 2018;52:724-32.

Hale G, Joseph T, Maravent S, Stern D, Alameddine S, Stultz K, Nieves A, Miller J, Scott K, Rodriguez MM, Perez A. Effect of interprofessional collaboration on quality of life in elderly patients with cardiovascular disease. J Interprof Educ Pract 2018;12:25-8.

Boylan P, Joseph T, Hale G, Moreau C, Seamon M, Jones R. Chronic obstructive pulmonary disease and heart failure self-management kits for outpatient transitions of care. Consult Pharm 2018;33:152-8.

Singh-Franco D, Hale G, Jacobs RJ. Oral anticoagulation therapy upon discharge in hospitalized patients with nonvalvular atrial fibrillation: a retrospective cohort study. Hosp Pract 2018;46:22-9.

Hale GM, Joseph T, Moreau C, Prados Y, Gernant S, Schneller M, Jones R, Seamon M, Rodriguez H. Establishment of outpatient rounds by an interprofessional chronic care management team. Am J Health Syst Pharm 2018;75:598-601.

Chaitin C, Velasquez J, Khanfar N, Chassange S, Perez Torres R, Loan Pham N, Rodriguez MM, Hale GM. Third year pharmacy students propose an interprofessional prediabetes educational program: PreDiaMe (Prediabetes + Me). J Interprof Care 2018;32:118-22.

Gonsai N, Amin V, Mendpara C, Speth R, Hale GM. Effects of dopamine receptor antagonist anti-psychotic therapy on blood pressure. J Clin Pharm Ther 2018;43:1-7.

Patel H, Simpson A, Palevoda G, Hale GM. Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults. J Clin Hypertens 2018;20:794-7.

McManara K, Witry M, Bryant G, Koenigsfeld C, Lehman N, Logemann C, Mormann M, Rueber A, Herring M, Hoehns JD. A prospective, multi-center cohort study: investigating the ability of warfarin-treated patients to predict their INR. Clin Res Cardiol 2018.

Babiker HM, McBride A, Newton M, Boehmer LM, Drucker AG, Gowan M, Cassagnol M, Camenisch TD, Anwer F, Hollands JM. Cardiotoxic effects of chemotherapy: a review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system. Crit Rev Oncol Hematol 2018;126:186-200.

Priftanji D, Cawley MJ, Finn LA, Hollands JM, Morel DW, Siemianowski LA, Bingham AL. Performance and retention of basic life support skills improve with a peer-led training program. Curr Pharm Teach Learn 2018;10:744-9.

Truby LK, Sridharan L, Flores RJ, Garan AR, Jennings D, Yuzefpolskaya M, Takeda K, Takayama H, Naka Y, Colombo PC, Topkara VK. Red cell distribution width predicts 90 day mortality in continuous-flow left ventricular assist device patients. ASAIO J 2018.

Jackevicius CA. Elephant in the room. Cost of proprotein convertase subtilisin/kexin type 9 inhibitors [editorial]. Circ Cardiovasc Qual Outcomes 2018;11:e004425.

Jackevicius CA, Lash D, Singh D, Hines K, Hata M. Accuracy and usability of pill identifiers for oral medications. J Am Coll Clin Pharm 2018. Published online ahead of print August 24, 2018.

Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gane JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD. Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes. The STIC2IT cluster randomized clinical trial. JAMA Intern Med 2018. Published online ahead of print August 6, 2018.

Joza J, Samuel M, Jackevicius CA, Behlouli H, Jia J, Koh M, Tsadok MA, Tang ASL, Verma A, Pilote L, Essebag V. Long-term risk of stroke and bleeding post-atrial fibrillation ablation. J Cardiovasc Electrophysiol 2018. Published online ahead of print July 26, 2018.

Ko DT, Tu JV, Krumholz HM, Austin PC, Ross JS, Stukel TA, Koh M, Chong A, Jackevicius CA. Clinical outcomes of Plavix and generic clopidogrel for patients hospitalized with an acute coronary syndrome. Circ Cardiovasc Qual Outcomes 2018;11:e004194.

Vira P, Nazer L, Phung OJ, Jackevicius CA. A longitudinal evidence-based medicine curriculum and its impact on the attitudes, knowledge and behavior of student pharmacists. Am J Pharm Ed 2018. Published online ahead of print.

Jennings DL, Lange N, Shullo M, Baker WL. Mammalian target of rapamycin inhibitors and survival in heart transplant recipients: miracle or mirage? J Am Coll Cardiol 2018;71:2859-60.

Jennings DL, Lange N, Shullo M, Latif F, Restaino S, Topkara VK, Takeda K, Takayama H, Naka Y, Farr M, Colombo P, Baker WL. Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: a meta-analysis. Int J Cardiol 2018;265:71-6.

Lee CL, Colombo PC, Eisenberger A, Diuguid D, Jennings DL, Han J, Salna MP, Takeda K, Takayama H. Abciximab/heparin therapy for left ventricular assist device implantation in patients with heparin-induced thrombocytopenia. Ann Thorac Surg 2018;105:122-8.

Lee CL, Eisenberger AB, Jennings DL, Takayama H. Abciximab/heparin during acute heparin-induced thrombocytopenia: a word of caution (reply). Ann Thorac Surg 2018;106:309-10.

Martinez BK, Yik B, Tran R, Ilham S, Coleman CI, Jennings DL, Baker WL. Meta-analysis of time in therapeutic range in continuous-flow left ventricular assist device patients receiving warfarin. Artif Organs 2018;42:700-4.

Dietrich JN, Kazmi H. Bleeding risks in patients on percutaneous ventricular assist devices receiving two different dextrose concentrations of heparinized purge solution: a case series. J Pharm Pract 2018. [Epub ahead of print]

Kennedy SP, Iaizzo H, Fayn E, et al. Evaluation of the impact of an institution-specific dofetilide initiation protocol on mean hospital length of stay and cost for dofetilide initiation. Pharmacoecon Open 2018.

Kido K, Guglin M. Anticoagulation therapy in specific cardiomyopathies: isolated left ventricular non-compaction and peripartum cardiomyopathy. J Cardiovasc Pharmacol Ther. [Epub ahead of print]

Kido K, Ngorsuraches S. Comparing the efficacy and safety of direct oral anticoagulants with warfarin in the morbidly obese population with atrial fibrillation. Ann Pharmacother. Accepted for publication.

Kido K, Oyen A, Beckmann M, Brouse S. Musculoskeletal toxicities of patients receiving concomitant statin and daptomycin therapy: do statins need to be held while on daptomycin? Am J Health Syst Pharm. Accepted for publication.

Lee CR, Sriramoju VB, Cervantes A, Howell LA, Varunok N, Madan S, Hamrick K, Polasek MJ, Lee JA, Clarke M, Cicci JD, Weck KE, Stouffer GA. Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention. Circ Genom Precis Med 2018;11:e002069.

Dong OM, Li A, Suzuki O, Oni-Orisan A, Gonzalez R, Stouffer GA, Lee CR, Wiltshire T. Projected impact of a multi-gene pharmacogenetic test to optimize medication prescribing in cardiovascular patients. Pharmacogenomics 2018;19:771-82.

Schafer JH, Casey AL, Dupre KA, Staubes BA. Safety and efficacy of apixaban versus warfarin in patients with advanced chronic kidney disease. Ann Pharmacother 2018 Jun 1. [Epub ahead of print]

Schumacher C, Moaddab G, Colbert M, Kliethermes MA. The impact of the clinical pharmacist on readmission rates of heart failure patients in the accountable care environment. J Manag Care Spec Pharm 2018;24:795-9.

Lamprecht DG Jr, Shaw PB, King JB, Hogan K, Olson KL. Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service. J Clin Lipidol 2018;12:999-1007.

Phelps E, Delate T, Witt DM, Shaw PB, McCool KH, Clark NP. Effect of increased time in therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service. Thromb Res 2018;163:54-9.

Ko JS, Guo S, Hassel J, Celestino-Soper P, Lynnes TC, Tisdale JE, Zheng JJ, Taylor SE, Foroud T, Murray MD, Kovacs RJ, Li X, Lin SF, Chen Z, Vatta M, Chen PS, Rubart M. Ondansetron blocks wildtype and p.F503L variant small conductance calcium activated potassium channels. Am J Physiol Heart Circ Physiol 2018 [Epub ahead of print]

Tomaselli Muensterman E, Tisdale JE. Predictive analytics for identification of patients at risk for QT interval prolongation – a systematic review. Pharmacotherapy 2018;38:813-21.

Van Tassell BW, Lipinski MJ, Appleton D, Roberts CS, Kontos MC, Abouzaki N, Melchior R, Mueller G, Garnett J, Canada J, Carbone S, Buckley LF, Wohlford G, Kadariya D, Trankle CR, Oddi Erdle C, Sculthorpe R, Puckett L, DeWilde C, Shah K, Angiolillo D, Vetrovec G, Biondi-Zoccai G, Arena R, Abbate A. Rationale and design of the Virginia Commonwealth University – Anakinra Remodeling Trial-3 (VCU-ART3): a randomized placebo-controlled double-blinded multicenter study. Clin Cardiol 2018 Jul 23. [Epub ahead of print]

Abbate A, Van Tassell BW. Levosimendan in advanced heart failure: where do we stand? J Cardiovasc Pharmacol 2018;71:127-8.

Abouzaki NA, Christopher S, Trankle C, Van Tassell BW, Carbone S, Mauro AG, Buckley L, Toldo S, Abbate A. Inhibiting the inflammatory injury after myocardial ischemia reperfusion with plasma-derived alpha-1 antitrypsin: a post hoc analysis of the VCU-αstudy. J Cardiovasc Pharmacol 2018;71:375-9.

Toldo S, Austin D, Mauro AG, Mezzaroma E, Van Tassell BW, Marchetti C, Carbone S, Mogelsvang S, Gelber C, Abbate A. Low-density lipoprotein receptor-related protein-1 is a therapeutic target in acute myocardial infarction. JACC Basic Transl Sci 2017;2:561-74.

Toldo S, Van Tassell BW, Abbate A. Interleukin-1 blockade in acute myocardial infarction and heart failure: getting closer and closer. JACC Basic Transl Sci 2017;2:431-3.

Wiggins BS, Morris PB. Dyslipidemias, atherosclerosis, and coronary heart disease. In: Applied Therapeutics, 11th ed. 2018.

New ACCP Fellows

Scott Bolesta

Steven Dunn

Christopher Ensor

Steven Smith

Diana Sobieraj

Other Notable Achievements

Cynthia Jackevicius: Fellow of the American College of Cardiology (FACC).

Oksana Kamneva: Director, PGY2 Cardiology Pharmacy Residency Program, UNC REX Healthcare.

Tien Ng: Fellow, American College of Cardiology.

James E. Tisdale:
Fellow, American College of Cardiology.
Peer Reviewer, 2018 American Psychiatric Association (APA) Resource Document on QTc Prolongation and Psychotropic Medications.
Abstract Reviewer, 2018 American Heart Association Scientific Sessions.

Barbara Wiggins:
Co-chair, Pharmacology Section, American College of Cardiology Annual Planning Committee.
Chair, Cardiovascular Team Pharmacists Committee, American College of Cardiology.

The ACCP CNS PRN elections are under way, and the PRN is accepting applications for the student and resident travel award for the 2018 ACCP Global Conference on Clinical Pharmacy in Seattle, Washington. A student-directed survey has been developed with guidance from the PRN leadership and will likely be sent to members in the next 1–2 months. The CNS PRN would like to congratulate the following members on their awards, activities, and accomplishments.

Promotions

Peter D. Anderson: Lieutenant Colonel, Medical Service Corps, U.S. Army Reserve.

Marshall E. Cates: Department Chair, April.

Jack J. Chen: Senior Associate Dean for Academic Affairs, School of Pharmacy, American University of Health Sciences (Signal Hill, California).

Publications

Caballero J, Benavides S, Clauson KA, Hardigan PC, Martinez BK, Llerena V. Non-modifiable determinants of pharmacy residency match rates. Int J Pharm Pract 2018;26:81-4.

Caballero J, Ownby RL, Jacobs RJ, Pandya N, Hardigan PC, Cabrera-Ricabal L. Predicting medication adherence in older Hispanic patients with type 2 diabetes. Am J Health Syst Pharm 2018;75:e194-e201.

Caballero J, Sedlacek J. Dementia-related disorders MTM data set. In: Whalen K, Hardin HC, eds. Medication Therapy Management; A Comprehensive Approach, 2nd ed. New York: McGraw-Hill, 2018:313-24.

Chen JJ, Hewitt LA. Comparison of the pharmacokinetics of droxidopa after dosing in the fed versus fasted state and with 3-times-daily dosing in healthy elderly subjects. Drugs R D 2018.

Faulkner MA. Use of α2δ ligands for restless legs syndrome/Willis Ekbom disease. CNS Drugs 2018;32:149-59.

Phan SV. Phenobarbital monotherapy for alcohol withdrawal syndrome in the non-intensive care unit setting: a review. Drugs Ther Perspect 2018;34:429-36.

Other Notable Achievements/Activities

Stephanie Nichols: Will be inducted as a Fellow of ACCP this year.

James L. Roerig: Elected to Alpha Omega Alpha Medical Society – Faculty Membership.

Publications

Abraham TG, Huggins C, Diaz-Fuentes G, Roglieri J. Combining pharmacy expertise with asthma educator certification: assessing the impact on inner-city asthma patients. J Asthma 2018:1-17. [Epub ahead of print]

Borchert JS, Phillips J, Thompson ML, Livingood A, Andersen R, Brasher C, Bright D, Fahmi-Armanious B, Leary M, Lee JC. ACCP white paper. Best practices: incorporating pharmacy technicians and other support personnel into the clinical pharmacist’s process of care. JACCP 2018. [Epub ahead of print]

Dong J, Adunlin G, Reeves L, et al. A systematic review of the effectiveness of text message reminders on asthma medication adherence. Innov Pharm. In press.

Green DM, Wang M, Krasin MJ, Srivastava D, Relling MV, Howell CR, Ness KK, Kaste SC, Greene W, Jay DW, Fernandez-Pineda I, Pui CH, Jeha S, Bishop MW, Furman WL, Robison LL, Hudson MM. Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study. Hepatology 2018 Jul 17.

Quinn M, Fannin JT, Sciasci J, Bragg A, Campbell PK, Carias D, Crews KR, Gregornik D, Jeha S, Maron G, Pauley JL, Swanson HD, Wolf J, Greene W. Pentamidine for prophylaxis against Pneumocystis jirovecii pneumonia in pediatric oncology patients receiving immunosuppressive chemotherapy. Antimicrob Agents Chemother 2018;62(8).

Herink MC, Irwin AN, Zumach GM. FDA breakthrough therapy designation: evaluating the quality of the evidence behind the drug approvals. Pharmacotherapy 2018. [Epub ahead of print]

Jobin J, Irwin AN, Pimentel J, Tanner MC. Accuracy of medication histories collected by pharmacy technicians during hospital admission. Res Social Adm Pharm 2018;14:695-9.

Peck A, Irwin AN. Lessons learned from implementation of a “geriatric-friendly” admission order set. J Pharm Tech 2018;34:181-2.

McConnell KJ. 2017 ACC/AHA guidelines for BP management in adult patients. Pharmacy Today 2018;24:57-73.

McConnell KJ. Blood pressure management in adult patients. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updates in Therapeutics®: Cardiology Pharmacy Preparatory Review Course, 2018 ed. Lenexa, KS: American College of Clinical Pharmacy, 2018:707-53.

Michalets E, Harris L. Antifibrinolytics: pharmacologic profile and clinical utilization. In: Topaz On, ed. Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions. Elsevier, 2018. In press.

Michalets EL, Williams C, Park I. Ten-year experience with student pharmacist research within a health system and education center. Curr Pharm Teach Learn 2018;10:316-24.

ASHP Student Leadership Awards

Austin Green

Jordan Mendkoff

Appointments and Promotions

Cindy Brasher:
ACCP Clinical Administration Chair-Elect 2018–2019.
Adjunct Assistant Professor, UNC Eshelman School of Pharmacy.
ASHP SPPM Section Advisory Group on Patient Care Quality 2018–2019.

Adriane Irwin: Distinguished Faculty Award for Excellence, Oregon Health & Science University, May 2018.

Karen J. McConnell: System Director of Clinical Pharmacy Services, Catholic Health Initiatives.

Elizabeth Michalets: Full Professor in the Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy.

Harminder Sikand:
Appointed to the ASHP Commission on Credentialing.
Received Full Professor status for UCSF and UCSD.

Promotions

Trisha Branan: University of Georgia College of Pharmacy Clinical Associate Professor.

Oksana Kamneva: Critical Care and Cardiology Pharmacy Manager at UNCREX.

Dustin Linn: Manchester University College of Pharmacy Associate Professor of Pharmacy Practice.

Scott Mueller: University of Colorado Skaggs School of Pharmacy Associate Professor.

Nick Peters: Suburban Hospital Pharmacy Clinical Educator.

Edward Van Matre: University of Tennessee College of Pharmacy Assistant Professor.

Matthew Wanat: University of Houston College of Pharmacy Clinical Assistant Professor.

Awards

Anas Mustafa AlHomran: Board Certification in Critical Care Specialty.

Angela Bingham: Leahy Award for Learning Innovations, University of the Sciences.

Kara Birrer:
Preceptor of the Year 2017–2018, Orlando Regional Medical Center Pharmacy Residency Program Leadership Award for Excellence.
Neurocritical Care Society’s Travel Grant Award for the 16th Annual Meeting.

Mitchell Buckley: SCCM Barry A. Shapiro Memorial Award for Excellence in Critical Care Management.

Joe Dasta: Shubin-Weil Master Clinician/Teacher: Excellence in Bedside Teaching Award, 2018.

Chris Droege:
First Place, GCSHP Best Practices and Research Symposium; Jacob CM, Philpott C, Ernst NE, Droege CA, Mueller EW. Pharmacokinetic evaluation of vancomycin in patients receiving continuous renal replacement therapy.
Second Place, GCSHP Best Practices and Research Symposium; Waugh PA, Keegan SP, Droege CA, Ernst NE, Mueller EW. Validation of an argatroban dosing protocol in an academic medical center: a retrospective, single health-system cohort study
Nomination: Rho Chi Lecture Award; the Rho Chi Society; the University of Cincinnati James L. Winkle College of Pharmacy.
Presidential Citation – Society of Critical Care Medicine.

Alex Flannery: CHEST Foundation Travel Grant.

Lana Gettman: 2017–2018 Teacher Achievement Award.

Mojdeh Heavner: Critical Care PRN Clinical Practitioner Award.

Scott Mueller: Presidential Teaching Award.

Janise Phillips: 2018 Cleveland Clinic Abu Dhabi Safety Champion.

John Radosevich:
2017–2018 APPE Preceptor of the Year – Midwestern University (Glendale).
PGY1 Preceptor of the Year – St. Joseph’s Hospital & Medical Center.

Paul Reynolds: Distance Degree Educator of the Year.

Pamela Smithburger: Rufus A. Lyman Award for outstanding article in the American Journal of Pharmaceutical Education 2018.

Matthew Wanat: Young Investigator Award and Top Rated Poster – International Society of Thrombosis and Hemostasis Congress, Dublin Ireland.

Grants

Melissa Thompson Bastin: 2018 ASHP Foundation Practice Advancement Initiative Grant $75,000 grant. “Implementing a Pharmacist-Managed Personalized Medicine Dosing Protocol for Beta-Lactam Antibiotics in Critically Ill Patients: A Prospective Observational, Sequential Period, Pilot Study.”

Brittany D. Bissell: ASHP Foundation New Investigator Grant.

Scott Bolesta: Continued Faculty and Peer-To-Peer Mentored Research in Cardiovascular Science. Submitted March 2018; Wilkes University. Amount requested: $7314 in direct costs. Submitted. Funding period: 06/01/2018 – 08/31/2018. Receiving agency/agent: Wilkes University. Funded for $6877.

Alex Flannery: Co-Investigator for ASHP Pharmacy Practice Advancement Demonstration Grant (Principal Investigator M. Thompson Bastin) and ASHP New Investigator Research Grant (Principal Investigator B. Bissell).

Mojdeh Heavner: Peter Lamy Center on Drug Therapy and Aging Pilot Funds for Aging Research. Title: Assessing the Relationship of Sleep and Circadian Pattern to Incidence of Delirium in Older Critically Ill Patients; funding: $5000; role: Co-Investigator.

Soo Min Jang: Merck, internal funding within Loma Linda University School of Pharmacy.

Publications

Priftanji D, Cawley MJ, Finn LA, Hollands JM, Morel DW, Siemianowski LA, Bingham AL. Performance and retention of basic life support skills improve with a peer-led training program. Curr Pharm Teach Learn 2018;10:744-9.

Bissell BD, Browder K, McKenzie M, Flannery AH. A blast from the past: revival of angiotensin II for vasodilatory shock. Ann Pharmacother 2018. [Epub ahead of print]

Bissell BD, Davis JE, Flannery AH, Adkins DA, Bastin ML. Aggressive treatment of life-threatening hypophosphatemia during recovery from fulminant hepatic failure: a case report. J Intensive Care Med 2018;33:375-9.

Magee CA, Bastin MLT, Laine ME, Bissell BD, Howington GT, Moran PR, McCleary EJ, Owen GD, Kane LE, Higdon EA, Pierce CA, Morris PE, Flannery AH. Insidious harm of medication diluents as a contributor to cumulative volume and hyperchloremia: a prospective, open-label, sequential period pilot study. Crit Care Med 2018;46:1217-23.

McCleary EJ, Thompson Bastin ML, Bissell BD, Cook AM, Pierce CA, Flannery AH. Development of a co-precepting model for a preceptor-in-training program for new practitioners. Hosp Pharm 2018. [Epub ahead of print]

Bolesta S. Specialized topics in cardiovascular disease. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updates in Therapeutics®: Cardiology Pharmacy Preparatory Review Course, 2018 ed. Lenexa, KS: American College of Clinical Pharmacy, 2018:231-70.

Buckley MS, Rasmussen JR, Bikin DS, Richards E, Berry AJ, Culver MA, Rivosechhi RM, Kane-Gill SL. Evaluation of trigger alerts associated with laboratory abnormalities on preventing adverse drug events in the intensive care unit and general ward. Ther Adv Drug Saf 2018;9:207-17.

Dasta J, Kamat S, Sundar S, Chase S, Lingohr-Smith M, Menges B, Lin J. Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia. Hosp Pract. Published online August 2, 2018.

Gottlieb M, DeMott JM, Hallock M, Peksa GD. Systemic antibiotics for the treatment of skin and soft tissue abscesses: a systematic review and meta-analysis. Ann Emerg Med 2018 Mar 9.

Hirschy R, Ackerbauer KA, Peksa GD, O’Donnell EP, DeMott JM. Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction. Am J Emerg Med 2018 Apr 27.

Hunt TV, DeMott JM, Ackerbauer KA, Whittier WL, Peksa GD. Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease. Clin Kidney J 19 July 2018.

Humphrey M, Everhart S, Kosmisky D, Anderson W. An evaluation of patient-specific characteristics on attainment of target sedation in an intensive care unit. Heart Lung 2018;47:387-91.

Srour H, Pandya K, Flannery A, Hatton K. Enteral guanfacine to treat severe anxiety and agitation complicating critical care after cardiac surgery. Semin Cardiothorac Vasc Anesth 2018 Apr 1. [Epub ahead of print]

Bissell BD, Browder K, McKenzie M, Flannery AH. A blast from the past: revival of angiotensin II for vasodilatory shock. Ann Pharmacother 2018;52:920-7.

Magee CA, Thompson Bastin ML, Laine ME, Bissell BD, Howington GT, Moran PR, McCleary EJ, Owen GD, Kane LE, Higdon EA, Pierce CA, Morris PE, Flannery AH. Insidious harm of medication diluents as a contributor to cumulative volume and hyperchloremia: a prospective, open-label, sequential period pilot study. Crit Care Med 2018;46:1217-23.

McCleary EJ, Thompson Bastin ML, Bissell BD, Cook AM, Pierce CA, Flannery AH. Development of a co-precepting model for a preceptor-in-training program for new practitioners. Hosp Pharm 2018. [Epub ahead of print]

Woolum JA, Abner EL, Kelly A, Thompson Bastin ML, Morris PE, Flannery AH. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit Care Med 2018 Jul 18. [Epub ahead of print]

Lee YJ, Gettman L. Descriptive analysis of acceptance by prescribers and economic benefit of pharmacist recommended interventions in a critical care unit. Innov Pharm 2018;9.

Groth CM, Acquisto NM, Khadem T. Current practices and safety of medication use during rapid sequence intubation. J Crit Care 2018;45:65-70.

Horner D, Altshuler D, Droege C, Feih J, Ferguson K, Fiorenza M, Greathouse K, Hamilton LA, Pfaff C, Roller L, Stollings J, Wong A. Major publications in the critical care pharmacotherapy literature: January-December 2016. J Crit Care 2018;43:327-39.

Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, Kakkera K, Chopra D, Meena N. Prospective open-label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock. Pharmacotherapy 2018;38:531-8.

Hammond DA, James TB, Atkinson LN, Painter JT, Lusardi K. Changing the time of blood collection to determine vancomycin concentrations in intensive care unit patients. Crit Care Nurse 2018;38:24-8.

Hammond DA, McGinn K, Rech MA, Grgurich P, Wells Mulherin D, Gonzales JP, Berger K. Professional benefits of a web-based journal club for critical care residents and their mentors. Am J Pharm Educ 2018. [Epub ahead of print]

Hammond DA, Stojakovic J, Kathe N, Tran J, Clem OA, Erbach K, King J. Deficiencies of magnesium replacement in the critically ill. J Intensive Care Med 2018;33:327.

Heavner MS, Masich AM, Claeys KC, Gonzales JP. Pharmacokinetic and pharmacodynamic considerations of antibiotics of last resort in treating gram-negative infections in adult critically ill patients. Curr Infect Dis Rep 2018;20:10.

Heavner MS, Nguyen NK, Knauert MP, Verceles A, Pisani MA, Seung H, Gonzales JP. Survey of clinical pharmacist perceptions and practices in promoting sleep in intensive care unit patients. JACCP 2018. Published online ahead of print.

Heavner JJ, Akgun K, Heavner MS, Eng CY, Drew M, Jackson P, Pritchard DA, Honiden S. Implementation of an ICU-specific alcohol withdrawal syndrome management protocol reduces the need for mechanical ventilation. Pharmacotherapy 2018;38:701-13.

Littlefield AJ, Heavner MS, Chan CY, Heavner JJ, Cooper C, Kurtz D, Pisani MA. The correlation between mMINDS and CIWA-Ar scoring tools in alcohol withdrawal patients. Am J Crit Care 2018;27:280-6.

Masich AM, Heavner MS, Gonzales JP, Claeys KC. Pharmacokinetic/pharmacodynamic considerations of beta-lactam antibiotics in adult critically ill patients. Curr Infect Dis Rep 2018;20:9.

Hecht JP, Richards PG. Continuous-infusion labetalol vs. nicardipine for hypertension management in acute stroke patients. J Stroke Cerebrovasc Dis 2018;27:460-5.

Gregory J, Hecht JP. Esophageal perforation: a research review of the anti-infective treatment. Int J Clin Pharm.

Beckett RD, Linn DD, Tellor KB, Sheehan AH, Montagano JK, Vonada B. Systematic evaluation of the methodological quality of clinical practice guidelines intended for pharmacists. J Am Coll Clin Pharm 2018;1-12.

Poyant JO, Albright R, Clain J, Pandompatam G, Barreto EF. Extracorporeal elimination of butalbital in acute aspirin-butalbital-caffeine-codeine (Fiorinal with codeine) poisoning. Clin Toxicol (Phila) 2018;56:439-41.

Poyant JO, Kuper PJ, Dierkhising RA, Rabinstein AA, Wijdicks EFM, Ritchie BM. Nicardipine reduces blood pressure variability after spontaneous intracerebral hemorrhage. Neurocrit Care 2018. [Epub ahead of print]

Asal NJ, Poyant JO. Role and impact of student pharmacists and a pharmacist on an international interprofessional medical brigade. Curr Pharm Teach Learn 2018. [Epub ahead of print]

Barreto EF, Poyant JO, Hongchuan HC, Dierkhising RA, Kennedy CC, Gajic O, Nystrom EM, Takahashi N, Moynagh MR, Kashani KB. Validation of the sarcopenia index to assess muscle mass in the critically ill: a novel application of kidney function markers. Clin Nutr 2018. [Epub ahead of print]/p>

Radosevich JJ, Feldman JP, Dutt M. Catastrophic circulatory collapse following an inadvertent subcutaneous injection of treprostinil. Am J Health Syst Pharm 2018;75:e300-4.

Shurtleff V, Radosevich JJ, Patanwala AE. Comparison of ketamine versus non-ketamine based sedation on delirium and coma in the intensive care unit. J Intensive Care Med 2018.

Reynolds P. Augmented renal clearance. Accepted for publication in: Critical Care Self-Assessment Program (CCSAP). Lenexa, KS: American College of Clinical Pharmacy.

Reynolds P. Stress ulcer prophylaxis vs placebo meta-analysis. Pharmacotherapy. Accepted for publication.

Smith SE, Hamblin SE, Guillamondegui OD, Gunter OL, Dennis BM. Effectiveness and safety of continuous neuromuscular blockade in trauma patients with an open abdomen: a follow-up study. Am J Surg 2018 Apr 18. [Epub ahead of print]

Smith SE, Rumbaugh KA. False prolongation of international normalized ratio with daptomycin. Am J Health Syst Pharm 2018;75:269-74.

Samai K, Vilella A. Update in therapeutics: prophylactic antibiotics in open fractures. J Trauma Nurs 2018;25:83-6.

New Fellows

Leslie Hamilton: American College of Critical Care Medicine (FCCM).

Scott Mueller: American College of Critical Care Medicine (FCCM).

Matthew Wanat: American College of Critical Care Medicine (FCCM).

Board Certifications

Anas Mustafa AlHomran: BCPS and BCCCP.

Jason Hecht: BCCCP.

Oksana Kamneva: BCPS.

Nathan Lian: BCCCP.

Michelle Poole: BCCCP.

Paul Reynolds: BCCCP.

Leadership Positions

Karen Berger:
NYSCHP, NYC Chapter President; NYSCHP Education and Professional Development Committee Chair; NYSCHP Grassroots Advocacy Committee Chair.
ASHP Yearlong Educational Steering Committee Vice Chair.
SCCM CPP Member-at-Large and SCCM Adult Item Writing Committee Co-Chair.

Angela Bingham:
Clinical Specialist Member, Board of Pharmacy Specialties, Nutrition Support Pharmacy Specialty Council.
Chair, Membership Committee, American Society for Parenteral and Enteral Nutrition.

Kara Birrer: Immediate Past President, ACCP Perioperative Care PRN.

Scott Bolesta: Chair-Elect, SCCM Research Section.

Trisha Branan: President-Elect, Georgia Society of Health-System Pharmacists.

Sonia Everhart: Education Committee Chair for Carolinas/Virginias Chapter of the Society of Critical Care Medicine.

Alex Flannery: Chair, Social Media Committee for ACCP Critical Care PRN and Vice Chair 2018 ACCP Annual Meeting Program Committee.

Leslie Hamilton: Secretary, Pharmacy Practice Section, ACCP.

Drayton Hammond: Chair, Critical Care PRN; Chair-Elect, SCCM CPP Section Education Committee; and Vice Chair, ACCP 2019 Programming Committee.

Mojdeh Heavner: Vice Chair, Critical Care PRN Research Committee.

Judith Jacobi: Chair, 2018 ACCP Presidential Task Force.

Nick Peters: Chair, Recognition Committee for the ACCP Critical Care PRN.

Janelle Poyant: Student/Resident/Fellow Committee Vice Chair, ACCP Critical Care PRN.

Pamela Smithburger: Co-Chair, SCCM Quality Summit.

Melissa Thompson Bastin: Member, SCCM Discovery Network Steering Committee.

Edward Van Matre: Resident/Fellow Board Liaison, ACCP Critical Care PRN.

Toni Vilella: Student/Resident/Fellow Chair, ACCP Critical Care PRN.

Matthew Wanat: President/Past President, Society of Critical Care Medicine, Texas Chapter.

Other Notable Achievements

Kristen Bamberg: Vice Chair, Board of Pharmacy Specialties Critical Care Council.

Brittany D. Bissell: Scientific Review Committee, Society of Critical Care Medicine.

Christine Groth: PGY2 Critical Care Program Director, University of Rochester Medical Center./p>

Drayton Hammond: PGY2 Critical Care Program Director, Rush University Medical Center.

Mojdeh Heavner: Coordinator, Pharmacotherapy PGY1/PGY2 Residency Program at UMB SOP.

Oksana Kamneva: PGY2 Cardiology Program Director, UNCREX Hospital.

Yukon Kuskokwim: PGY1 Residency Completion.

Nathan Lian:
Implemented DKA Protocol.
Approved Propofol as Post-intubation Sedation in the ED.
Implemented Pharmacy Aspects for Telestroke Services for the facility to become a Primary Stroke Center.
Nominated as a member of the Pharmacy Residency Board.

Scott Mueller: Director, PGY2 Critical Care Program.

Matthew Wanat:
Director, PGY2 Residency Program.
Created a Fellowship in Academic Pharmacy at UH.

The DI PRN has been providing live and recorded webinars on drug information topics to its members. Its most recent webinar was presented by Lauren Koppen, Pharm.D., BCPS, titled “Team-Based Learning Approach to Teaching Tertiary Resources.” The DI PRN also hosts student and resident journal club presentations on a variety of topics. Journal clubs are presented live and recorded. The most recent journal club was presented by Lindsay Slowiczek, Pharm.D., titled “Non-opioids for Chronic Pain: Pragmatic or an Idea from Outer Space?”

Awards

Kelsey Bridgeman: 2018 Drug Information PRN Student Travel Award.

Mandy Leonard: Ohio College of Clinical Pharmacy (OCCP) Pharmacist of the Year Award.

Dan Majerczyk: Roosevelt University College of Pharmacy 2018 Preceptor of the Year Award.

Michelle W. McCarthy: Virginia Commonwealth University School of Pharmacy Office of Experiential Education 2018 Outstanding Service Award.

Presentations

Neff DR, Johnson ST, Stevenson JG, Smith, ST. Formulary decision making in oncology – a panel discussion. Michigan Society of Hematology-Oncology 6th Annual Oncology Pharmacists Forum; May 2018; Troy, MI.

Rodriguez R, Bridgeman K. Descriptive analysis of evidence-rating systems used in contemporary meta-analyses of drug effects. Poster presented at: American College of Clinical Pharmacy Global Conference; October 20–23, 2018; Seattle, WA (accepted).

Publications

Ottman AA, Warner CB, Brown JN. The role of mirtazapine in patients with fibromyalgia: a systematic review. Clin Rheumatol 2018 Jun 2. [Epub ahead of print]

Watkins AK, Gee ME, Brown JN. A systematic review of the efficacy and safety of levetiracetam for migraine prophylaxis. J Clin Pharm Ther 2018;43:467-75.

Gonzalez J, Bridgeman M, Hermes-DeSantis E. Differentiating predatory scholarship: best practices in scholarly publication. Int J Pharm Pract 2018;26:73-6.

Gonzalez J, Bryant S, Hermes-DeSantis ER. Transdermal estradiol for the management of refractory uremic bleeding. Am J Health Syst Pharm 2018;75:e177-e183.

Narayanan N, Lacy C, Cruz J, Nahass M, Karp J, Barone J, Hermes-DeSantis ER. Disaster preparedness: biological threats and treatment options. Pharmacotherapy 2018;38:217-34.

Kaufman MB:
Pharmaceutical Approval Update. P T 2018;43:22, 23, 60.
Pharmaceutical Approval Update. P T 2018;43:83-4.
Pharmaceutical Approval Update. P T 2018;43:141-2.
Certolizumab pegol receives FDA approval for plaque psoriasis plus FDA updates ixekizumab label to include genital-area psoriasis. Rheumatologist 2018;12:80.
Drug safety: fasinumab evaluated in clinical trials plus celecoxib may not pose increased heart attack or stroke risk & more. Rheumatologist 2018;12:64.
FDA to review abuse deterrent oxycodone plus adalimumab biosimilar moves forward after legal battle & more. Rheumatologist 2018;12:67.
Ixekizumab promising for AS plus certolizumab pegol & psoriasis, heart risk with clarithromycin & more. Rheumatologist 2018;12:50.
Ferumoxytol injection receives new indication plus application for GP2017 moves ahead & loperamide abuse reported. Rheumatologist 2018;12:64.
Bimekizumab improves joint & skin symptoms in PsA patients plus EU approves certolizumab pegol for pregnant & nursing patients. Rheumatologist 2018;12:80.
E6011 safe & well tolerated in RA patients plus tocilizumab monotherapy may sustain low disease activity in RA patients. Rheumatologist 2018;12:72.

Leonard MC, Bauer SR, Ahrens CL, Reddy A, Katzan I. Institutional care paths: development, implementation, and evaluation. Am J Health Syst Pharm 2017;74:1486-93.

Leonard MC, Thyagarajan R, Wilson A, Sekeres M. Effective formulary management and clinical care processes across the patient care continuum. Am J Health Syst Pharm 2017;75:451-5.

Schroer B, Bjelac J, Leonard MC. What’s new in managing patients with food allergy? Almost everything. Curr Opin Pediatr 2017;29:578-83.

Wisniewski CS. Development and impact of a simplified approach to didactic PowerPoint presentations performed in a drug information course. Curr Pharm Teach Learn 2018;10:291-7.

Other

Dan Majerczyk: Served as a 2018 Walmart Scholar Mentor, sponsored by the American Association of Colleges of Pharmacy.

Christopher S. Wisniewski: Earned Master’s Degree in Science and Clinical Research at the Medical University of South Carolina.

Promotions

Holly Gurgle: Associate Professor (Clinical), University of Utah College of Pharmacy.

Dustin Linn: Associate Professor of Pharmacy Practice, Manchester University College of Pharmacy.

Awards

Emily Frederick: Teacher of the Year (2017–2018).

Holly Gurgle: 2018 APhA Immunization Champion – National Individual Practitioner Award.

Lucas Hill:
Texas Pharmacy Association Generation Rx Champion Award.
UT School of Undergraduate Studies Distinguished University Lecturer.

Beth H. Resman-Targoff: Rho Chi National Honor Society’s 2018 Faculty Advisor Award.

Grants

Lucas Hill: Principal Investigator: Texas Targeted Opioid Response Overdose Prevention Project. Texas Health & Human Services Commission ($2,587,149). 2017–2019.

Publications

Caballero J, Benavides S, Clauson KA, Hardigan PC, Martinez BK, Llerena V. Non-modifiable determinants of pharmacy residency match rates. Int J Pharm Pract 2018;26:81-4.

Caballero J, Ownby RL, Jacobs RJ, Pandya N, Hardigan PC, Cabrera-Ricabal L. Predicting medication adherence in older Hispanic patients with type 2 diabetes. Am J Health Syst Pharm 2018;75:e194-e201.

Caballero J, Sedlacek J. Dementia-related disorders MTM data set. In: Whalen K, Hardin HC, eds. Medication Therapy Management; A Comprehensive Approach, 2nd ed. New York: McGraw-Hill, 2018:313-24.

Diehl B, Dy-Boarman EA, Bottenberg MM, Mobley-Bukstein W. Utilizing desirable difficulties for sterile compounding training in a skills-based laboratory course. Curr Pharm Teach Learn 2018;10:469-72.

Burris JN, Frederick EK, Malcom DR, Raake S, Shin M, Daugherty KK. Impact of a journal club elective course on student learning measures. Am J Pharm Ed. Published online ahead of print June 7 2018.

Hill L. Harm reduction approaches to opioids. In: Schepis TS, ed. The Prescription Drug Abuse Epidemic: Incidence, Prevention, Treatment, and Policy. Santa Barbara, CA: ABC-CLIO, 2018:227-41.

Kabakov A, Kolanczyk D. Book review of: Soric MM, Schneider SR, Wisneski SS. The Effective Pharmacy Preceptor. Bethesda, MD: American Society of Health-System Pharmacists, 2017.

Beckett RD, Linn DD, Tellor KB, Sheehan AH, Montagano JK, Vonada B. Systematic evaluation of the methodological quality of clinical practice guidelines intended for pharmacists. J Am Coll Clin Pharm 2018;1-12.

Rac H, Wagner JL, King ST, Barber KE, Stover KR. Impact of an antifungal stewardship intervention on optimization of candidemia management. Ther Adv Infect Dis 2018;5:3-10.

Joyner KR, Soric MM, Boyle JA, Moorman JM, Fredrickson ME, Turosky JZ, Kleven CL. Mineralocorticoid receptor antagonist utilization in a nationally representative heart failure with reduced ejection fraction outpatient population: a cross-sectional study. Am J Ther 2018.

Stover KR, Ballou J, Liles AM, Fleming LW, Fleming JW, Riche DM, Pitcock JJ, King ST, Capino A. Assessment of the landscape of clinical productivity tracking via reporting of quality patient indicators. J Am Coll Clin Pharm 2018;1-8.

Stover KR, King ST, Barber KE. Impact of an infectious diseases advanced pharmacy practice experience on student knowledge. Curr Pharm Teach Learn 2018;10(8). Online ahead of print June 2018.

Chastain DB, King ST, Stover KR. Achieving urinary antibiotic concentrations to effectively treat resistant organisms. BMC Res Notes 2018;11:497.

White BP, Wagner JL, Barber KE, King ST, Stover KR. Risk factors for failure in complicated intra-abdominal infections. South Med J 2018;111:125-32.

Wingler MJB, Epperson TM, Stover KR, Wagner JL, Barber KE. Acute bacterial skin and skin structure infections (ABSSSI): new and emerging treatment options. MAD-ID Newsletter Continuing Education Article 2018;8:6-23.

New ACCP Fellows (2018)

Suzanne G. Bollmeier

Lingtak-Neander Chan

Christina M. Madison

Stephanie Nichols

Patricia R. Wigle

Other Notable Achievements

Beth H. Resman-Targoff: National invited presentation on “Joint Effort: Working with Patients with Osteoarthritis and Rheumatoid Arthritis” at: American Pharmacists Association Annual Meeting and Exposition; March 2018; Nashville, TN.

Todd Sorensen: President-Elect, AACP.

Awards

Kara L. Birrer: Pharmacy Preceptor of the Year, Orlando Regional Medical Center; Travel Grant Award, Neurocritical Care Society Annual Meeting.

Natalija Farrell: Pharmacy Preceptor of the Year, Boston Medical Center.

Kristan V. Higgs: Owensboro Health President’s Award, Owensboro Health Regional Hospital.

Megan A. Rech: Pharmacy Preceptor of the Year, Loyola University Medical Center.

Kyle Weant: Pharm to Table Award, Medical University of South Carolina; for outstanding contribution to emergency medicine physician resident education.

Promotions

Kristan V. Higgs: Interim Director, PGY1 Pharmacy Residency Program, Owensboro Health Regional Hospital.

Darrel Hughes: Clinical Pharmacy Practice Manager, University Health System & University of Texas Health – San Antonio.

Megan A. Rech: Adjunct Assistant Professor – Department of Emergency Medicine, Stritch School of Medicine, Loyola University Chicago.

Publications

Acquisto NM, Bodkin RP, Brown JE, Graman PS, Jones CMC, Li T, Hardy DJ, Dodds Ashley E. The value of MRSA carriage status for treatment of skin and soft tissue infections in the emergency department. Emerg Med J 2018. [Epub ahead of print]

Dylla L, Acquisto NM, Manzo F, Cushman JT. Dexamethasone related perineal burning in the prehospital setting: a case series. Prehosp Emerg Care 2018. [Epub ahead of print]

Groth C, Acquisto NM, Khadem T. Current practices and safety of medication use during rapid sequence intubation: a multicenter study evaluating practices across the United States. J Crit Care 2018;45:65-70.

Janda M, Acquisto NM, Gashlin L, Dodds Ashley E. Increasing the quality of medication histories in the emergency department with pharmacy students. Am J Emerg Med 2017. [Epub ahead of print]

Loner C, Acquisto NM, Lenhardt H, et al. Accuracy of intravenous infusion flow regulators in the prehospital environment. Prehosp Emerg Care 2018.

Morgan S, Acquisto NM, Coralic Z, Basalyga V, Campbell M, Kelly JJ, Langkiet K, Pearson C, Sokn E, Phelan M. Clinical pharmacy services in the emergency department. Am J Emerg Med 2018. [Epub ahead of print]

Awad NI. Scrubs and a scarf. In: Walter LA, ed. Perspectives: Women in Emergency Medicine. Dallas, TX: American College of Emergency Physicians, 2017.

Bilhimer MH, Schult RF, Higgs KV, Wiegand TJ, Gorodetsky RM, Acquisto NM. Acute intoxication following dimethyltryptamine ingestion. Case Rep Emerg Med 2018.

Curry D, Birrer KL, Carothers C. Comparison of intracranial pressure reduction between 7.5% and 23.4% hypertonic saline. Neurocrit Care 2018;29(suppl 1).

DeMott JM, Hebert CL, Novak M, Mahmood S, Peksa GD. Characteristics and resource utilization of patients presenting to the emergency department from mass gathering events. Am J Emerg Med 2017. [Epub ahead of print]

DeMott JM, Patel G, Lat I. Evaluating the effects of chronic antihypertensives on vasopressor dosing in septic shock. Ann Pharmacother 2018;52:40-7.

Gottlieb M, DeMott JM, Hallock M, Peksa GD. Systemic antibiotics for the treatment of skin and soft tissue abscesses: a systematic review and meta-analysis. Ann Emerg Med 2018. [Epub ahead of print]

Hunt TV, DeMott JM, Ackerbauer KA, Whittier WL, Peksa GD. Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease. CKJ 2018. [Epub ahead of print]

Fowler AF, Hughes DW, Muir MT, VanWert EM, Gamboa CD, Myers JG. Resource utilization after snakebite severity score implementation into treatment algorithm of crotaline bite. J Emerg Med 2017. [Epub ahead of print]

Kaucher KA, Acquisto NM, Broderick K. Emergency department naloxone rescue kit dispensing and patient follow-up. Am J Emerg Med 2017. [Epub ahead of print]

Hirschy R, Ackerbauer KA, Peksa GD, O’Donnell EP, DeMott JM. Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction. Am J Emerg Med 2018. [Epub ahead of print]

Rech MA, Colon Hidalgo D, Larson J, Zavala S, Mosier M. Vitamin D in burn-injured patients. Burns 2018. [Epub ahead of print]

Hammond DA, McGinn K, Rech MA, Grgurich P, Wells Mulherin D, Gonzales JP, Berger K. Professional benefits of a web-based journal club for critical care residents and their mentors. Am J Pharm Educ 2018. [Epub ahead of print]

Hirschy R, Davis T, Shah T, Rech MA. Treatment of life-threatening ACE-inhibitor induced angioedema. Adv Emerg Nurs J 2018. [Epub ahead of print]

Hirschy R, Sterk E, Rech MA. Time spent in the emergency department and outcomes in patients with severe sepsis and septic shock. Adv Emerg Nurs J 2018;40:94-103.

Steuber H, Williams D, Rech MA. Leave the levofloxacin? A case report of levofloxacin-induced psychosis. Am J Emerg Med 2018 May 1. [Epub ahead of print]

Schult R, Acquisto NM. Acetaminophen and aspirin. In: Critical Care Self-Assessment Program (CCSAP). Toxicology. Lenexa, KS: American College of Clinical Pharmacy, May 2018.

Schultz R, Acquisto NM, King C, Wiegand T. A case of lionfish envenomation presenting to an inland emergency department. Case Rep Emerg Med 2017.

Slouch GW, Schult R, Gorodetsky R, Wiegand T, Kamali M, Acquisto NM. Pregabalin and paradoxical reaction of seizures in a large overdose. Toxicol Commun 2018;2:19-20.

Waybright RA. Traumatic spinal cord injury. In: Neurocritical Care ON CALL. Neurocritical Care Society.

Matuskowitz AJ, Abukhdeir H, Weant K, Calhoun C, Domangue B, Caporossi J. Evidence-based management of atrial fibrillation in the emergency department. Emerg Med Rep April 1, 2018.

Linder LM, Ross CA, Weant KA. Ketamine for the acute management of excited delirium and agitation in the prehospital setting. Pharmacotherapy 2018;38:139-51.

McPheeters CM, Wiedmar JA, Pinkston CM, Weant KA. Implications of statin use on vasopressor therapy in the setting of septic shock. Hosp Pharm 2018;53:152-6.

New Fellows

Derrel Hughes

Other Notable Achievements

Peter D. Anderson: Lieutenant Colonel, Medical Service.

The Endocrine and Metabolism PRN consists of pharmacists and student pharmacists from a variety of practice settings. The PRN was formed to achieve the following goals and objectives: (1) provide an opportunity for pharmacists with an interest in endocrine and metabolism disorders to promote practice, research, and education in these areas; (2) provide a mechanism for members with similar interests to meet during ACCP meetings to network, problem solve, and discuss professional issues and opportunities; and (3) promote practice involvement; educational needs of health care professionals, students, and patients; and research activities in the areas of endocrinology and metabolism that may be favorably affected by this ACCP PRN effort. During the past 6 months, notable member accomplishments include the following.

Promotions

Jennifer D’Souza: Professor with Tenure.

Krystal L. Edwards: Full Professor effective September 1, 2018.

S. Mimi Mukherjee: Associate Professor.

Sara (Mandy) Reece: Director of Interprofessional Education.

Awards

Dustin Carneal: Preceptor of the Year, NEOMED College of Pharmacy (selected by Class of 2019) and Faculty Excellence in Role Modeling Interprofessional Collaboration, NEOMED College of Pharmacy.

Molly Minze: Abilene campus Preceptor of the Year, Texas Tech University Health Sciences Center School of Pharmacy.

Publications

Anderson SL, Marrs JC. Characterization of statin therapy in a managed care population with diabetes. J Clin Lipidol 2018;12:536.

Anderson SL, Marrs JC. The role of the pharmacist in heart failure transition of care. Adv Ther 2018;35:311-23.

Anderson SL, Marrs JC. Direct oral anticoagulant (DOAC) use in valvular heart disease. Clin Med Insights Ther 2018;10:1-6.

Anderson SL, Trujillo JM, Anderson JE, Tanenberg R. Switching basal insulins – practical recommendations for health care providers. Postgrad Med 2018;130:229-38.

Marrs JC, Anderson SL, Gabriel C. Role of aldosterone receptor antagonists in heart failure with preserved ejection fraction. Clin Med Insights Ther 2018;10:1-9.

Kugler AJ, Thiman ML. Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data. Diabetes Metab Syndr Obes 2018;11:187-97.

Karwa R, Maina M, Pastakia SD, et al. Leveraging peer-based support to facilitate HIV care in Kenya. PLoS Med 2017;14:e1002355.

Mercer T, Gardner A, Andama B, Chesoli C, Christoffersen-Deb A, Dick J, Einterz R, Gray N, Kimaiyo S, Kamano J, Maritim B, Morehead K, Pastakia SD, Ruhl LJ, Songok J, Laktabai J. Leveraging the power of partnerships: spreading the vision for a population health care delivery model in western Kenya. Global Health 2018;14:44.

Njuguna BN, Kiplagat J, Bloomfield J, Pastakia SD, Vedanthan R, Koethe JR. Prevalence, risk factors, and pathophysiology of dysglycemia among people living with HIV in sub-Saharan Africa. J Diabetes Res 2018;2018:Article ID 6916497.

Park P, Pastakia SD. Access to hemoglobin A1c in rural Africa: a difficult reality with severe consequences. J Diabetes Res 2018. In press.

Reece SW, Parihar HS, Martinez M. Retrospective review of maternal and fetal outcomes in patients with gestational diabetes mellitus in an indigent prenatal clinic. Diabetes Spectr 2018;31:200-5.

Schumacher C, Moaddab G, Colbert M, Kliethermes MA. The impact of the clinical pharmacist on readmission rates of heart failure patients in the accountable care environment. J Manag Care Spec Pharm 2018;24:795-9.

Patel RS, Scopelliti EM, Olugbile O. The role of PCSK9 inhibitors in the treatment of hypercholesterolemia. Ann Pharmacother. Published online ahead of print April 18, 2018.

Williams E, Martin SL, Fabrikant A, et al. Rates of depressive symptoms among pharmacy residents. Am J Health Syst Pharm 2018;75:292-7.

Podium Presentations

Clements J. Pharmacotherapy for obesity in type 1 diabetes. 78th American Diabetes Association Scientific Sessions; June 2018; Orlando, FL.

Dela Pena L. Updates in GLP1 agonists. 7th Annual Midwestern University Updates in Diabetes and Related Chronic Care Topics Pharmacy Continuing Education Conference; June 2018; Downers Grove, IL.

D’Souza J: Updates in the 2018 ADA Standards of Care. 7th Annual Midwestern University Updates in Diabetes and Related Chronic Care Topics Pharmacy Continuing Education Conference; June 2018; Downers Grove, IL.

Schumacher C:
Guidelines for non-insulin medication management in patients with type 2 diabetes. Presented as a live webinar at: American Association of Diabetes Educators; April 2018.
130 is the new 140: an update in the management of hypertension. 7th Annual Midwestern University Updates in Diabetes and Related Chronic Care Topics Pharmacy Continuing Education Conference; June 2018; Downers Grove, IL.
Clearing the confusion: considerations for management of diabetes and chronic kidney disease. 7th Annual Midwestern University Updates in Diabetes and Related Chronic Care Topics Pharmacy Continuing Education Conference; 2018 June. Downers Grove, IL.

Schumacher C, Kliethermes M. Successful practice models in team-based care. Presented as a live webinar at: American Pharmacists Association; June 2018.

Van Dril E. Double trouble: considerations for the management of type 2 diabetes in patients with chronic heart failure. 7th Annual Midwestern University Updates in Diabetes and Related Chronic Care Topics Pharmacy Continuing Education Conference; June 2018; Downers Grove, IL.

Wesling M. Sometimes less is more – the art of deintensifying. 7th Annual Midwestern University Updates in Diabetes and Related Chronic Care Topics Pharmacy Continuing Education Conference; June 2018; Downers Grove, IL.

Poster Presentations

Thomas M, Dewnani K, Novotny K, Lange M, Brown F, Fermo J. The role of pharmacy in the Million Hearts initiative. American College of Clinical Pharmacy Updates in Therapeutics®; February 2018; Jacksonville, FL.

Macmaster HW, Fong I, Rushakoff RJ. Making sense of rapid-acting insulin patient directions in the EMR. 78th American Diabetes Association Scientific Sessions; June 2018; Orlando, FL.

Macmaster HW, Maruoka A, San Luis C, Gonzalez S, Rushakoff RJ. Inpatient use of insulin pens – eliminating risk for inappropriate use of pen on more than one patient. 78th American Diabetes Association Scientific Sessions; June 2018; Orlando, FL.

Macmaster HW, Tran A, Monash B, Murray SG, Prasad PA, Rushakoff RJ. Decreasing incidence of postinsulin hypoglycemia for hyperkalemia treatment. 78th American Diabetes Association Scientific Sessions; June 2018; Orlando, FL.

Rushakoff RJ, Zook J, Macmaster HW. Documentation of continuous subcutaneous insulin infusion (CSII) use in the emergency department (ED). 78th American Diabetes Association Scientific Sessions; June 2018 June; Orlando, FL.

New ACCP Fellows

Molly Minze

Notable Achievements

Sarah Anderson: Appointed to the ASHP Council on Therapeutics (2018–2019).

Drew Klinkebiel: Board Certified in Advanced Diabetes Management.

Anne Kugler: Accepted as a MeRIT participant for 2018–2020.

Anne Misher: Accepted as a MeRIT participant for 2018–2020.

Sara (Mandy) Reece: Board Certified in Ambulatory Care Pharmacy.

The GI/Liver/Nutrition PRN would like to congratulate its members on their exceptional accomplishments reported March 2018 – August 2018. Way to go and keep up the great work! Many thanks to all of you for your superb contributions. Keep updated on GI/Liver/Nutrition PRN activities, new articles, professional meeting highlights, and discussions on the PRN’s Facebook page as well as its new Twitter account. Follow the PRN at @accpGILNprn. Please join the PRN on September 13 for a career panel webinar with PRN member-panelists excited to discuss their unique pharmacy career paths. Panelists will share their experiences, provide professional insights, and spark new career interests for pharmacists-in-training, new practitioners, and those looking to learn about different opportunities. PRN members also hope to see you at the 2018 ACCP Global Conference on Clinical Pharmacy in Seattle, Washington. The PRN focus session will provide updates and guidance on the management of pediatric and adult intestinal failure–associated liver disease.

Awards

Angela Bingham: ACCP New Educator Award.

Publications

Dickerson RN, Kumpf VJ, Bingham AL, Blackmer A, Canada TW, Chan LN, Cogle SV, Tucker AM. Significant published articles for pharmacy nutrition support practice in 2017. Hosp Pharm 2018;53:239-46.

Smith AN. Neurohormonal influences on obesity. Bariatric Times 2017;14:10-4.

Smith AN. Nutritional considerations in the bariatric surgery patient. In: Murphy JE, Lee MW, eds. Ambulatory Care Self-Assessment Program, 2017. Nutritional/Gastroenterologic Care. Lenexa, KS: American College of Clinical Pharmacy, 2017.

Ramsdell T, Smith AN, Kerkhove E. Compliance with updated sepsis bundles to meet new sepsis core measure in a tertiary care hospital. Hosp Pharm 2017;52:177-86.

Other Notable Achievements

Kelsey Rife: Elected as President-Elect, Ohio College of Clinical Pharmacy.

April Smith: Elected to the Integrated Health Executive Committee of the American Society for Metabolic and Bariatric Surgery.

Presentations

April Smith:
Implementing ENERGY techniques into your practice. Invited podium presentation at: ASMBS Weekend; June 15, 2018; New York, NY.
How does the pharmacist fit in to ERAS? Invited podium presentation at: 18th Annual Minimally Invasive Surgery Symposium; March 7, 2018; Las Vegas, NV.
Opioid crisis in America: can ERAS help? Invited podium presentation at: 18th Annual Minimally Invasive Surgery Symposium; March 6, 2018; Las Vegas, NV.
Pharmacist’s role on the bariatric surgery team. Invited faculty for webinar sponsored by: Greater New York Health Association. 1.0 hour CE webinar given November 21, 2017.
Clinical practice hot topics in bariatric surgery & pharmacology. Integrated Health Pharmacology Course: Obesity Week 2017; October 30, 2017; Washington, DC.

Grants

Melanie Nicol: “Pharmacology of Antiretrovirals in Anatomical Brain Tissue Among Persons with Chronic HIV Infection.” Sponsor: NIH NINDS/Fogarty International Center (R21).

Publications

Pastakia SD, Ferris RP, Tran DN, Manji IN. Building reliable supply chains for non-communicable disease commodities: lessons learned from HIV and evidence needs. AIDS 2018;32(suppl 1):S55-S61.

Bernard C, Pekny C, Omukugah C, Bernard C, Manji IN, Pastakia SD, Christoffersen-Deb, AC. Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception. Contraception 2018. In press.

Mercer T, Gardner A, Andama B, Chesoli C, Christoffersen-Deb A, Dick J, Einterz R, Gray N, Kimaiyo S, Kamano J, Maritim B, Morehead K, Pastakia SD, Ruhl LJ, Songok J, Laktabai J. Leveraging the power of partnerships: spreading the vision for a population health care delivery model in western Kenya. Global Health 2018;14:44.

Njuguna B, Kiplagat J, Bloomfield J, Pastakia SD, Vedanthan R, Koethe JR. Prevalence, risk factors, and pathophysiology of dysglycemia among people living with HIV in sub-Saharan Africa. J Diabetes Res 2018;2018:Article ID 6916497.

Njuguna B, Vorkoper S, Patel P, Reid M, Vedanthan R, Pfaff C, Park P, Fischer L, Laktabai J, Pastakia SD (corresponding author). Models of integration of HIV and non-communicable disease care in sub-Saharan Africa: lessons learned and evidence gaps. AIDS 2018;32(suppl 1):S33-S42.

Park P, Pastakia SD. Access to hemoglobin A1c in rural Africa: a difficult reality with severe consequences. J Diabetes Res 2018;2018:Article ID 6093595.

Patel PR, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, Vorkoper S, Pastakia SD, Rausch D, Levitt NS. Non-communicable diseases among persons living with HIV in low- and middle-income countries: a systematic review of cardiovascular disease, cervical cancer, depression, and diabetes. AIDS 2018;32(suppl 1):S5-S20.

Prescott GM, Mullen T, Wilson-Clarke C, Gossell-Williams M, Morse GD. Development and implementation of an introductory pharmacy practice experience in Kingston, Jamaica to expose students to global health. Am J Pharm Educ 2018;82:Article 7158.

Prescott GM, Mullen T, Wilson-Clarke C, Lombardo JC, Tsuji BT, Lindo J, Morse GD, Gossell-Williams M. An international collaboration on sustainable workforce development and implementation of a doctor of pharmacy program. Am J Pharm Educ 2018;82:Article 7158.

Presentations

Helen Berlie: Integrating global health into the Pharm.D. curriculum. Presented at: AACP Annual Meeting; July 2018; Boston, MA.

Sonak Pastakia:
Models of integration of HIV and non-communicable disease care in sub-Saharan Africa: lessons learned and evidence gaps. Invited panelist at: International AIDS Society Meeting; July 23, 2018; Amsterdam, Netherlands.
Strengthening health systems through partnerships. Invited panelist at: Partnership for Quality Medical Donations Annual Meeting; April 11, 2018; Washington, DC.

Gina M. Prescott:
Integrating global health into the Pharm.D. curriculum. AACP Annual Meeting; July 2018; Boston, MA.
Lindo JF, Mullen T, Prescott G, Smith D, Wilkes R, Longsworth L, Paul T, Talal A, Sethi S, Lombardo J, Furlani T, Fernando A, Delgado R, McDonald A, Govindaraju V, DeHovitz J, Morse G. Integrated biomedical research platform to achieve health and well-being sustainable development goals. Sustainable Futures for the Caribbean: Critical Interventions and the 2030 Agenda, Sir Arthur Lewis Institute of Social & Economic Studies (SALISES), 19th Annual Conference; April 2018; Montego Bay, Jamaica.

Douglas Slain:
Accommodating international exchange and visiting students and scholars: are there best practices? (roundtable). Annual Meeting of the American Association of Colleges of Pharmacy (AACP); July 21–25, 2018; Boston, MA.
Preceptor development models in the US. 2018 U.S.-Thai Pharmacy Consortium Meeting, University of Kentucky; June 10–12, 2018; Lexington, KY.

Other Notable Achievements

Debra Goff: Global Antimicrobial Stewardship Expert (U.S.): Selected to work with the WHO to develop guidance, education, and toolkits for the 2019 implementation of antibiotic stewardship programs in low-middle income countries.

Promotions

Christopher Frei: Full Professor with Tenure (University of Texas at Austin).

Daniel R. Touchette: Full Professor (University of Illinois at Chicago).

Awards

Christopher Frei:
Graduate Teacher and Mentor of the Year Award, College of Pharmacy, University of Texas at Austin.
Educator of the Year Award, College of Pharmacy, University of Texas at Austin.

Grants

Christopher Frei: Institute for Integration of Medicine & Science: A Partnership to Improve Health, NIH/NCATS, $24M (5/1/18 – 4/30/23). 2018 May. Co-Principal Investigator for TL1 Program.

New ACCP Fellows

Diana Sobieraj

Publications

Sobieraj DM, Baker WL, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake K, Lang JE. Systematic Review of Intermittent Inhaled Corticosteroids and of Long-Acting Muscarinic Antagonists for Asthma. Comparative Effectiveness Review No. 194. Prepared by the University of Connecticut Evidence-Based Practice Center under Contract No. 290-2015-00012-I) AHRQ Publication No. 17(18)-EHC027-EF. Rockville, MD: Agency for Healthcare Research and Quality, March 2018.

Weeda ER, Caranfa JT, Lyman GH, Kuderer NM, Nguyen E, Coleman CI, et al. External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer. Supportive Care Cancer 2018 [Epub ahead of print]

The Hematology/Oncology PRN continues to provide a forum for hematology/oncology pharmacists to network and collaborate on scientific, educational, and political issues affecting clinical practice, teaching, and research. The PRN has 795 members, with trainees (students and residents) making up almost 50% of the membership.
     At the 2017 Annual Meeting, the PRN hosted resident and student travel awardees. Because of increased student membership and the desire for more opportunities to connect, the second half of the PRN meeting served as a networking session focused on members’ clinical and research activities. The PRN was asked to increase student involvement; therefore, the PRN has created activities geared toward trainees. The PRN also formed a committee within, which includes trainees, to help the PRN officers complete their initiatives.
     The PRN has made plans to donate to the Frontiers Fund, and nominations for 2018 awards have been submitted. Plans for PRN collaboration are under way for the 2018 PRN focus session.

Promotions

Pamala A. Pawloski: Senior Research Investigator, HealthPartners Institute.

Grants

S. Monestime: $30,000 grant from the University of North Texas Institute of Patient Safety to implement a patient safety initiative at the Center for Cancer and Blood Disorders.

Publications

Cooper JB, Turner M, Patel M, Markle J, Amend C, Absher R, Roh J. Evaluation of an evidence-based medicine curriculum in a PGY1 pharmacy residency program using the Fresno test. Am J Pharm Educ 2018;82:6294.

Avila JC, Livingston JA, Rodriguez AM, Kirchhoff AC, Kuo YF, Kaul S. Disparities in adolescent and young adult sarcoma survival: analyses of the Texas Cancer Registry and the National SEER data. J Adolesc Young Adult Oncol 2018 Aug 10.

Ge S, Beechinor RJ, Hornik CP, Standing JF, Zimmerman K, Cohen-Wolkowiez M, Laughon MM, Clark R, Gonzalez D. External evaluation of a gentamicin infant population pharmacokinetic model using data from a national electronic health record database. Antimicrob Agents Chemother 2018.

Bhattacharyya GS, Walia M, Nandi M, Murli A, Salim S, Rajpurohi S, Shinde S, Aggarwal S, Parikh PM. Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer. South Asian J Cancer 2018.

Cho JC, Dunn RL, Yu FS, Loredo GA, Brazill BJ. Characteristics of antimicrobial stewardship programmes in rural East Texas hospitals. J Hosp Infect 2018.

Bubalo J. Managing the mental distress of the hematopoietic stem cell transplant (HSCT) patient: a focus on delirium. Curr Hematol Malig Rep 2018;13:109-13.

Bubalo J, Mulverhill K, Meyers G, Hayes-Lattin B, Maziarz R. A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT). Bone Marrow Transplant 2018.

Bubalo JS, Herrington JD, Takemoto M, Willman P, Edwards MS, Williams C, Fisher A, Palumbo A, Chen E, Blanke C, Lopez CD. Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancer. Support Care Cancer 2018;26:1273-9.

Furuno JP, Tallman GB, Noble BN, Bubalo JS, Forrest GN, Lewis JS II, Bienvenida AF, Holmes CA, Weber BR, McGregor JC. Clinical outcomes of the oral suspension versus delayed-release tablet formulations of posaconazole for prophylaxis of invasive fungal infections. Antimicrob Agents Chemother 2018.

Rawson TM, Ming D, Gowers SA, Freeman DM, Herrero P, Georgiou P, Cass AE, O’Hare D, Holmes AH. Public acceptability of computer-controlled antibiotic management: an exploration of automated dosing and opportunities for implementation. J Infect 2018 Aug 9.

Clemmons AB, Orr J, Andrick B, Gandhi A, Sportes C, DeRemer D. Randomized, placebo-controlled, phase III trial of fosaprepitant, ondansetron, dexamethasone (FOND) versus FOND plus olanzapine (FOND-O) for the prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies receiving highly emetogenic chemotherapy and hematopoietic cell transplantation regimens: the FOND-O trial. Biol Blood Marrow Transplant 2018 Jun 13.

Gwynn ME, DeRemer DL. The emerging role of PD-1/PD-L1-targeting immunotherapy in the treatment of metastatic urothelial carcinoma. Ann Pharmacother 2018;52:60-8.

Dunaway S, Orwig KW, Arbogast ZQ, Myers ZL, Sizemore JA, Giancola SE. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia. Int J Clin Pharm 2018;40:526-32.

Lemke AA, Hulick PJ, Wake DT, Wang C, Sereika AW, Yu KD, Glaser NS, Dunnenberger HM. Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics 2018;19:321-31.

Patel JN, Wiebe LA, Dunnenberger HM, McLeod HL. Value of supportive care pharmacogenomics in oncology practice. Oncologist 2018 Apr 5.

Phillips EJ, Sukasem C, Whirl-Carrillo M, Müller DJ, Dunnenberger HM, Chantratita W, Goldspiel B, Chen YT, Carleton BC, George AL Jr, Mushiroda T, Klein T, Gammal RS, Pirmohamed M. Clinical Pharmacogenetics Implementation Consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update. Clin Pharmacol Ther 2018;103:574-81.

Oyler D, Bernard AC, VanHoose JD, Parli SE, Ellis CS, Li D, Procter LD, Chang PK. Minimizing opioid use after acute major trauma. Am J Health Syst Pharm 2018;75:105-10.

Seligson ND, Hobbs ALV, Leonard JM, Mills EL, Evans AG, Goorha S. Evaluating the impact of the addition of cladribine to standard acute myeloid leukemia induction therapy. Ann Pharmacother 2018;52:439-45.

Gatwood KS, Culos KA, Binari LA, Engelhardt BG, Kassim A, Byrne MT, Goodman SA, Chinratanalab W, Sengsayadeth SM, Greer JP, Jagasia M, Savani BN. Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia. Bone Marrow Transplant 2018;53:795-9.

McDonald MK, Culos KA, Gatwood KS, Prow C, Chen H, Savani BN, Byrne M, Kassim AA, Engelhardt BG, Jagasia M, Satyanarayana G. Defining incidence and risk factors for catheter-associated bloodstream infections in an outpatient adult hematopoietic cell transplantation program. Biol Blood Marrow Transplant 2018 May 9.

Sengsayadeth S, Labopin M, Boumendil A, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gatwood KS, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A. Transplant outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study. Biol Blood Marrow Transplant 2018;24:1406-14.

Sakoulas G, Geriak M, Nizet V. Is a reported penicillin allergy sufficient grounds to forgo the multidimensional antimicrobial benefits of β-lactam antibiotics? Clin Infect Dis 2018 Jul 9.

Thompson A, Blackmer A, Jeffres M, Glode A, Mahyari N, Thompson M. Clinical pharmacy academic career transitions: viewpoints from the field. Part 2: understanding and balancing the distribution of effort. Curr Pharm Teach Learn 2018;10:128-32.

Babiker HM, Glode AE, Cooke LS, Mahadevan D. Ublituximab for the treatment of CD20 positive B-cell malignancies. Expert Opin Investig Drugs 2018;27:407-12.

Blackmer AB, Thompson AM, Jeffres MN, Glode AE, Mahyari N, Thompson M. Clinical pharmacy academic career transitions: viewpoints from the field. Part 1: understanding feedback, evaluation, and advancement. Curr Pharm Teach Learn 2018;10:123-7.

Blackmer AB, Thompson AM, Jeffres MN, Glode AE, Thompson M, Mahyari N. Clinical pharmacy academic career transitions: viewpoints from the field. Curr Pharm Teach Learn 2018;10:121-2.

Jeffres MN, Blackmer AB, Thompson AM, Glode AE, Mahyari N, Thompson M. Clinical pharmacy academic career transitions: viewpoints from the field. Part 3: learning when and how to say yes. Curr Pharm Teach Learn 2018;10:133-6.

Goodin S. Pharmacists’ critical role in cancer clinical trials. Am J Health Syst Pharm 2018;75:592-3.

Wang Z, Zhang L, Wan Z, He Y, Huang H, Xiang H, Wu X, Zhang K, Liu Y, Goodin S, Du Z, Zheng X. Atorvastatin and caffeine in combination regulates apoptosis, migration, invasion and tumorspheres of prostate cancer cells. Pathol Oncol Res 2018 May 24.

Green DM, Wang M, Krasin MJ, Srivastava D, Relling MV, Howell CR, Ness KK, Kaste SC, Greene W, Jay DW, Fernandez-Pineda I, Pui CH, Jeha S, Bishop MW, Furman WL, Robison LL, Hudson MM. Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study. Hepatology 2018 Jul 17.

Quinn M, Fannin JT, Sciasci J, Bragg A, Campbell PK, Carias D, Crews KR, Gregornik D, Jeha S, Maron G, Pauley JL, Swanson HD, Wolf J, Greene W. Pentamidine for prophylaxis against Pneumocystis jirovecii pneumonia in pediatric oncology patients receiving immunosuppressive chemotherapy. Antimicrob Agents Chemother 2018;62(8).

Bhella S, Majhail NS, Betcher J, Costa LJ, Daly A, Dandoy CE, DeFilipp Z, Doan V, Gulbis A, Hicks L, Juckett M, Khera N, Krishnan A, Selby G, Shah NN, Stricherz M, Viswabandya A, Bredeson C, Seftel MD. Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group’s list of 5 tests and treatments to question in blood and marrow transplantation. Biol Blood Marrow Transplant 2018;24:909-13.

Hammerstrom AE, Lombardi LR, Pingali SR, Rondon G, Chen J, Milton DR, Chemaly RF, Champlin RE, Gulbis A, Ciurea SO. Prevention of cytomegalovirus reactivation in haploidentical stem cell transplantation. Biol Blood Marrow Transplant 2018;24:353-8.

Khouri IF, Fernandez Curbelo I, Turturro F, Jabbour EJ, Milton DR, Bassett RL Jr, Vence LM, Allison JP, Gulbis AM, Sharma P. Ipilimumab plus lenalidomide after allogeneic and autologous stem cell transplantation for patients with lymphoid malignancies. Clin Cancer Res 2018;24:1011-8.

Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O’Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol 2018 Aug 6.

Nieto Y, Thall PF, Ma J, Valdez BC, Ahmed S, Anderlini P, Popat U, Jones RB, Shpall EJ, Hosing C, Qazilbash M, Kebriaei P, Alousi A, Timmons M, Gulbis A, Myers A, Oki Y, Fanale M, Dabaja B, Pinnix C, Milgrom S, Champlin R, Andersson BS. Phase II trial of high-dose gemcitabine/busulfan/melphalan with autologous stem cell transplantation for primary refractory or poor-risk relapsed Hodgkin lymphoma. Biol Blood Marrow Transplant 2018 Mar 2.

Chahoud J, Sui D, Erwin WD, Gulbis AM, Korbling M, Zhang M, Ahmed S, Alatrash G, Anderlini P, Ciurea SO, Oran B, Fayad LE, Bassett RL Jr, Jabbour EJ, Medeiros LJ, Macapinlac HA, Young KH, Khouri IF. Updated results of rituximab pre- and post-BEAM with or without 90Yttrium ibritumomab tiuxetan during autologous transplant for diffuse large B-cell lymphoma. Clin Cancer Res 2018;24:2304-11.

Neelapu SS, Tummala S, Kebriaei P, Wierda W, Locke FL, Lin Y, Jain N, Daver N, Gulbis AM, Adkins S, Rezvani K, Hwu P, Shpall EJ. Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit “ALL.” Nat Rev Clin Oncol 2018;15:218.

Ragon BK, Mehta RS, Gulbis AM, Saliba RM, Chen J, Rondon G, Popat UR, Nieto Y, Oran B, Olson AL, Patel K, Hosing CM, Qazilbash MH, Shah N, Kebriaei P, Shpall EJ, Champlin RE, Alousi AM. Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit. Bone Marrow Transplant 2018;53:315-25.

Gupta N, Hanley MJ, Xia C, Labotka R, Harvey RD, Venkatakrishnan K. Clinical pharmacology of ixazomib: the first oral proteasome inhibitor. Clin Pharmacokinet 2018 Aug 17.

Lockhart AC, Bauer TM, Aggarwal C, Lee CB, Harvey RD, Cohen RB, Sedarati F, Nip TK, Faessel H, Dash AB, Dezube BJ, Faller DV, Dowlati A. Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors. Invest New Drugs. 2018 May 2. [Epub ahead of print]

Lyman GH, Balaban E, Diaz M, Ferris A, Tsao A, Voest E, Zon R, Francisco M, Green S, Sherwood S, Harvey RD, Schilsky RL. American Society of Clinical Oncology Statement: biosimilars in oncology. J Clin Oncol 2018;36:1260-5.

Lyman GH, Zon R, Harvey RD, Schilsky RL. Rationale, opportunities, and reality of biosimilar medications. N Engl J Med 2018;378:2036-44.

Moore DC, Arnall JR, Harvey RD. Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. J Oncol Pharm Pract 2018 Jul 31.

Owonikoko TK, Busari AK, Kim S, Chen Z, Akintayo A, Lewis C, Carthon BC, Alese OB, El-Rayes BF, Ramalingam SS, Harvey RD. Race-, age-, and gender-based characteristics and toxicities of targeted therapies on phase I trials. Oncology 2018;95:138-46.

Singh V, Gillespie TW, Harvey RD. Intranasal ketamine and its potential role in cancer-related pain. Pharmacotherapy 2018;38:390-401.

Szmulewitz RZ, Peer CJ, Ibraheem A, Martinez E, Kozloff MF, Carthon B, Harvey RD, Fishkin P, Yong WP, Chiong E, Nabhan C, Karrison T, Figg WD, Stadler WM, Ratain MJ. Prospective international randomized phase II study of low-dose abiraterone with food versus standard dose abiraterone in castration-resistant prostate cancer. J Clin Oncol 2018;36:1389-95.

Vishwanathan K, Dickinson PA, So K, Thomas K, Chen YM, De Castro Carpeño J, Dingemans AC, Kim HR, Kim JH, Krebs MG, Chih-Hsin Yang J, Bui K, Weilert D, Harvey RD. The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib. Br J Clin Pharmacol 2018;84:1156-69.

Bindal P, Jalil SA, Holle LM, Clement JM. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract 2018 Aug 9.

Kolesar JM, Liu GX. Low-fat abiraterone food effect is of little consequence. J Clin Oncol 2018;36:1385-6.

Moore DC, Arnall JR, Harvey RD. Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. J Oncol Pharm Pract. Published online ahead of print.

Moore DC, Lavery L. Olaratumab: a new strategy in the treatment of advanced soft-tissue sarcoma. J Adv Pract Oncol 2018;9:235-40.

Moore DC, Ringley JT. Rhabdomyolysis with abiraterone exposure: a review of the Food and Drug Administration Adverse Drug Event Reporting System. Ann Pharmacother. Published online ahead of print.

Patel J, Ringley JT, Moore DC. Case series of docetaxel-induced dorsal hand-foot syndrome. Ther Adv Drug Saf 2018;9:495-8.

Singhi E, Moore DC, Muslimani A. Metastatic soft tissue sarcoma: a review of treatment and new pharmacotherapies. P T 2018;43:410-5.

Cottreau C, Dashevsky I, Andrade S, Li D, Nekhlyudov L, Raebel MA, Ritzwoller D, Partridge A, Pawloski PA, Toh S. Pregnancy-associated cancer: a U.S. population-based study. J Womens Health. In press.

McMullen C. Bulkley J, Corley DA, Madrid S, Davis AQ, Hesselbrock R, Kurtilla F, Anderson CK, Arterburn D, Somkin CP, Pawloski PA, Ghai NR, Feigelson HS. Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL Colorectal Cancer Cohort Survey. J Support Care Cancer. Accepted for publication, May 2018.

Bergsbaken J, Roman D, Earl MA, McBride A, Olin JL, Peele A, Reichard JS. ASHP-HOPA guidelines on the roles and responsibilities of the pharmacy technician in ambulatory oncology pharmacy. Am J Health Syst Pharm 2018 Jul 13.

Serag-Bolos ES, Chudow M, Perkins J, Patel RV. Enhancing student knowledge through a comprehensive oncology simulation. Am J Pharm Educ 2018;82:6245.

Gillis NE, Taber TH, Bolf EL, Beaudet CM, Tomczak JA, White JH, Stein JL, Stein GS, Lian JB, Frietze S, Carr FE. Thyroid hormone receptor beta suppression of RUNX2 is mediated by Brahma-related gene 1-dependent chromatin remodeling. Endocrinology 2018;159:2484-94.

Trexler SE, Nguyen E, Gromek SM, Balunas MJ, Baker WL. Electrocardiographic effects of hawthorn (Crataegus oxyacantha) in healthy volunteers: a randomized controlled trial. Phytother Res 2018.

Bhat RR, Yadav P, Sahay D, Bhargava DK, Creighton CJ, Yazdanfard S, Al-Rawi A, Yadav V, Qin L, Nanda S, Sethunath V, Fu X, De Angelis C, Narkar VA, Osborne CK, Schiff R, Trivedi MV. GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer. Breast Cancer Res Treat 2018;170:279-92.

Ekinci E, Nathoo S, Korattyil T, Vadhariya A, Zaghloul HA, Niravath PA, Abughosh SM, Trivedi MV. Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? J Cancer Surviv 2018;12:348-56.

Promotions

Maya Campara: Clinical Associate Professor, Department of Pharmacy Practice and Department of Surgery, University of Illinois at Chicago (UIC).

Jeong Park: Clinical Professor of Pharmacy, University of Michigan.

Awards

Maya Campara:
2018 Fellow (FCCP), American College of Clinical Pharmacy.
2018, P2 Class, Lecturer of the Year Award, Class of 2020, University of Illinois at Chicago College of Pharmacy.

Publications

Kim Y, Jung AD, Dhar VK, Tadros JS, Schauer DP, Smith EP, Hanseman DJ, Cuffy MC, Alloway RR, Shields AR, Shah SA, Woodle ES, Diwan TS. Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. Am J Transplant 2018;18:410-6.

Bowman LJ, Brueckner AJ, Doligalski CT. The role of mTOR inhibitors in the management of viral infections: a review of current literature. Transplantation 2018;102(2S suppl 1):S50-S59.

Spaggiari M, Di Bella C, Di Cocco P, Campara M, Galen KL, Gheza F, Oberholzer J, Benedetti E, Tzvetanov I. Pancreas transplantation from pediatric donors: a single center experience. Transplantation 2018.

Dew MA, DiMartini AF, Dobbels F, Grady KL, Jowsey-Gregoire SG, Kaan A, Kendall K, Young QR, Abbey SE, Butt Z, Crone CC, De Geest S, Doligalski CT, Kugler C, McDonald L, Ohler L, Painter L, Petty MG, Robson D, Schlöglhofer T, Schneekloth TD, Singer JP, Smith PJ, Spaderna H, Teuteberg JJ, Yusen RD, Zimbrean PC. The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. J Heart Lung Transplant 2018;37:803-23.

Fleming JN, Taber DJ, Axelrod D, Chavin KD. The effect of Share 35 on biliary complications: an interrupted time series analysis. Am J Transplant 2018.

Pilch NA, Fleming JN, Crowther BR, Maldonado AQ, Taber DJ. It is time for board certification in transplant pharmacotherapy. Am J Transplant 2018.

Liu Q, Smith AR, Park JM, Oguntimein M, Dutcher S, Bello G, Helmuth M, Turenne M, Balkrishnan R, Fava M, Beil CA, Saulles A, Goel S, Sharma P, Leichtman A, Zee J. The adoption of generic immunosuppressant medications for kidney, liver, and heart transplantation among recipients in Colorado or nationally with Medicare Part D. Am J Transplant 2018;18:1764-73.

Potter LM, Maldonado AQ, Lentine KL, et al. Transplant recipients are vulnerable to coverage denial under Medicare Part D. Am J Transplant 2018;18:1502-9.

West-Thielke P, Progar K, Campara M, Jasiak N, Gallon L, Tang I, Spaggiari M, Tzvetanov I, Benedetti E. Eculizumab for prevention of antibody-mediated rejection in blood group-incompatible renal transplantation. Transplant Proc 2018;50:66-9.

Other Notable Achievements

Maya Campara: Content Developer and Editor. Petition to the Board of Pharmacy Specialties for the recognition of solid organ transplant pharmacists as specialists. ACCP clinical content expert. March 2018.

Lisa Potter: Elected as Councilor-at-Large to the American Society of Transplantation’s Board of Directors (2018–2020).

Abstract Poster Presentations

Campara M, West-Thielke P, Progar K, Jasiak N, Lichvar A, Tang I, Benedetti E. Infectious complications associated with eculizumab used for ABO-incompatible renal transplantation. Am J Transplant 2018; TBD(D165). American Transplant Congress; June 2018; Seattle, WA.

Moss M, Goebel J, Bock M. Impact of once-daily tacrolimus on adherence in stable adolescent and young adult renal transplant recipients. American Transplant Congress; June 2018; Seattle, WA.

Benz E, Sikora A, Moss M, Ray K, Goebel J, Bock M. Re-classification of blood pressure control using ambulatory blood pressure monitoring in children and young adults after kidney transplantation. Pediatric Academic Societies (PAS); May 2018; Toronto, Ontario, Canada.

Leek R, Park J, Koerschner C, Mawby J, Wright Nunes J, Sonnenday C, Sharma P. Assessment of a novel chronic kidney disease educational and goal setting tool among liver transplant recipients. American Transplant Congress; June 2–6, 2018; Seattle, WA.

Lu Y, Lyons J, Tischer S, Woodside K, Park J. Efficacy and safety of a single-dose rituximab for prevention of focal segmental glomerulosclerosis recurrence after kidney transplant. American Transplant Congress; June 2–6, 2018; Seattle, WA.

Shaikh S, Panek N, Park J. A national survey of valganciclovir dosing strategies in pediatric solid organ transplant recipients. American Transplant Congress; June 2–6, 2108; Seattle, WA.

Shaikh S, Samaniego M, Park J. Direct oral anticoagulation use in kidney transplant recipients. American Transplant Congress; June 2–6, 2018; Seattle, WA.

Pasternak AL, Kidwell K, Dempsey J, Sun Y, Hertz DL, Park JM. The impact of CYP3A5 genotype on tacrolimus trough concentrations varies between routes of administration. American Society of Clinical Pharmacology and Therapeutics; March 21–24, 2018; Orlando, FL.

Potter L, Garrity E. Medicare Part D plans to deny coverage for off-label and off-compendia immunosuppressant use: a case series. Abstract B341. Am J Transplant 2018;18(suppl 4).

Sullivan M, Lin J, Bag R, Potter L. Incidence of atrial arrhythmia after lung transplantation with a universal prophylaxis strategy. Abstract C269. Am J Transplant 2018;18(suppl 4).

West-Thielke P, Campara M, Tang I, Benedetti E. Outcomes of Hispanic kidney transplant recipients under a cyclosporine- versus tacrolimus-based immunosuppression protocol. Am J Transplant 2018; TBD(D155). American Transplant Congress; June 2018; Seattle, WA.

Session Moderators

Maya Campara and Lisa Potter: Assessing and addressing medication non-adherence in the “real-world” clinical setting. American Transplant Congress; June 2018; Seattle, WA.

Invited Presentations

Christina Doligalski:
The art, the science, the allure of transplantation: pharmacology. Invited presentation at: American Transplant Congress; June 2018; Seattle, WA.
Unique immunosuppression in pregnancy following solid organ transplantation. Invited presentation at: American Transplant Congress; June 2018; Seattle, WA.

Lisa Potter:
Efficacy of immunosuppression and impact of sex. Invited presentation at: American Transplant Congress; June 2018; Seattle, WA.
The ABC’s of immunosuppression billing in the ambulatory care setting. Invited presentation at: American Transplant Congress; June 2018; Seattle, WA.

The ID PRN continues to thrive. Its committees have successfully published newsletters, begun a Member Spotlight series, and organized networking events, and they continue to spread the word about pharmacists’ value in antimicrobial stewardship through the PRN’s active social media outlets (#IDPRN). Below is a sampling of professional achievements by ID PRN members.

Promotions

Sam Aitken: Program Director, PGY2 Infectious Diseases Pharmacy Residency, University of Texas MD Anderson Cancer Center.

Pamela Foral: Professor of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions.

Christopher Frei: Full Professor with Tenure, College of Pharmacy, University of Texas at Austin, September 2018.

Awards

Elias Chahine: 2018 Hero in Medicine Award, Healthcare Educator Higher Education Category awarded by the Palm Beach County Medical Society.

Lynne Fehrenbacher: Concordia University Wisconsin Pharmacy Practice Faculty of the Year, May 2018.

Christopher Frei: Educator of the Year Award, College of Pharmacy, University of Texas at Austin, May 2018.

Ashley Marx: PY3 Instructor of the Year, UNC Eshelman School of Pharmacy, April 2018.

Tracy Zembles: IDSA Antimicrobial Stewardship Center of Excellence Award.

Grants

Elias Chahine: Principal Investigator: Assessing Adherence to the 2017 IDSA/SHEA Clinical Practice Guidelines for Clostridium difficile Infection. Funding: Palm Beach Atlantic University Quality Initiative Grant $1500.

Christopher Frei: Institute for Integration of Medicine & Science: A Partnership to Improve Health, NIH/NCATS, $24M (5/1/18 – 4/30/23). May 2018. Chris Frei is the Co-Principal Investigator for the TL1 Program.

Debra Goff: A pharmacist-driven prospective collaborative study on adherence to the South African CAP guidelines in 23 public and private sector hospitals across South Africa. Merck stewardship grant.

Publications

Li X, Arias CA, Aitken SL, Galloway Peña J, Panesso D, Chang M, Diaz L, Rios R, Numan Y, Ghaoui S, DebRoy S, Bhatti MM, Simmons DE, Raad I, Hachem R, Folan SA, Sahasarabhojane P, Kalia A, Shelburne SA. Clonal emergence of invasive multidrug-resistant Staphylococcus epidermidis deconvoluted via a combination of whole-genome sequencing and microbiome analyses. Clin Infect Dis 2018;67:398-406.

Boylan PM, Joseph T, Hale GM, Moreau C, Seamon M, Jones R. Development of chronic obstructive pulmonary disease and heart failure self-management kits for outpatient transitions of care. Consult Pharm 2018;33:145-51.

Carr DR, Stiefel U, Bonomo RA, Burant CJ, Sims SV. A Comparison of cefazolin versus ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia in a tertiary care VA medical center. Open Forum Infect Dis 2018;5(5).

Chahine EB. The rise and fall of metronidazole for Clostridium difficile infection. Ann Pharmacother 2018;52:600-2.

Chahine EB. Sexually transmitted diseases, ambulatory care infections, and immunizations. In: Bland CM, Bookstaver PB, Chahine EB, et al, eds. Updates in Therapeutics®: Infectious Diseases Pharmacy Preparatory Review Course, 2018 ed. Lenexa, KS: ACCP, 2018:155-222.

Chahine EB, Cho JC, Worley MV. Bezlotoxumab for the prevention of Clostridium difficile recurrence. Consult Pharm 2018;33:89-97.

Chahine EB, Karaoui LR. Lung abscesses. In: Murphy JE, Len MW, eds. Pharmacotherapy Self-Assessment Program, 2018 Book 1. Infectious Diseases. Lenexa, KS: ACCP, 2018:161-89.

Chahine EB, Kelley D, Childs-Kean LM. Sofosbuvir/velpatasvir/voxilaprevir: a pan-genotypic direct-acting antiviral combination for hepatitis C. Ann Pharmacother 2018;52:352-63.

Dougherty JA, Chahine EB. Providing additional “muscles” for older adults through optimal vaccine selection. Ann Pharmacother 2018;52:936-41.

James SF, Chahine EB, Sucher AJ, Hanna C. Shingrix: the new adjuvanted recombinant herpes zoster vaccine. Ann Pharmacother 2018;52:673-80.

Chastain DB, King ST, Stover KR. Achieving urinary antibiotic concentrations to effectively treat resistant organisms. BMC Res Notes 2018;11:497.

Mandal S, Kang G, Prathipati PK, Fan W, Li Q, Destache CJ. Long-acting parenteral antiretrovirals loaded into a nano-drug delivery system for HIV-1 treatment: humanized mouse model study. Antivir Res 2018 Jun 6.

Prathipati PK, Mandal S, Destache CJ. Tenofovir, emtricitabine, elvitegravir, rilpivirine analysis on dried blood spots and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2018;e4270.

Dotson KM, Aitken SL, Sofjan AK, Shah DN, Aparasu RR, Garey KW. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect 2018;146:1101-5.

Foolad F, Aitken SL, Chemaly RF. Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients. Expert Rev Clin Pharmacol 2018 Jul 13. [Epub ahead of print]

Foolad F, Taylor BD, Shelburne SA, Arias CA, Aitken SL. Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review. J Antimicrob Chemother 2018 Mar 13. [Epub ahead of print]

Reveles KR, Mortensen EM, Koeller JM, Lawson KA, Pugh MJV, Rumbellow SA, Argamany JR, Frei CR. Derivation and validation of a Clostridium difficile infection recurrence prediction rule in a national cohort of veterans. Pharmacotherapy 2018.

Reveles KR, Pugh MJV, Lawson KA, Mortensen EM, Koeller JM, Argamany JR, Frei CR. Shift to community-onset Clostridium difficile infection in the national Veterans Health Administration, 2003-2014. Am J Infect Control 2018;46:431-5.

Ghazi IM, Monogue ML, Tsuji M, Nicolau DP. Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model. Int J Antimicrob Agents 2018;51:206-12.

Ghazi IM, Monogue ML, Tsuji M, Nicolau DP. Humanized exposures of cefiderocol, a siderophore cephalosporin, display sustained in vivo activity against siderophore-resistant Pseudomonas aeruginosa. Pharmacology 2018;101:278-84.

El Nekidy WS, Soong D, Kadri A, Tabbara O, Ibrahim A, Ghazi IM. Salvage of hemodialysis catheter in staphylococcal bacteremia: case series, revisiting the literature, and the role of the pharmacist. Case Rep Nephrol Dial 2018;8:121-9.

Goff DA. Antibiotic stewardship: the health of the world depends on it. Hosp Pharm 2018;53:214-6.

Goff DA, File T. The risk of prescribing antibiotics “just-in-case” there is infection. Semin Colon Rectal Surg 2018;29:44-8.

Pulcini C, Binda F, Lamkang AS, Trett A, Charani E, Goff DA, Harbarth S, Hinrichsen SL, Levy-Hara G, Mendelson M, Nathwani D, Gunturu R, Singh S, Srinivasan A, Thamlikitkul V, Thursky K, Vlieghe E, Wertheim H, Zeng M, Gandra S, Laxminarayan R. Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clin Microbiol Infect 2018 Apr 3.

Srinivas P, Hunt LN, Pouch SM, Thomas K, Goff DA, Pancholi P, Balada-Llasat JM, Bauer KA. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates. Diagn Microbiol Infect Dis 2018;91:194-8.

Tacconelli E, et al.; WHO Pathogens Priority List Working Group (Goff DA). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018;18:318-27.

Goodlet KJ, Fairman KA. Adverse events associated with antibiotics and intravenous therapies for post-Lyme disease syndrome in a commercially insured sample. Clin Infect Dis 2018 Apr 17. [Epub ahead of print]

Almarzoky Abuhussain SS, Goodlet KJ, Nailor MD, Nicolau DP. Optimizing skin and skin structure infection outcomes: considerations of cost of care. Expert Rev Pharmacoecon Outcomes Res 2018;18:235-44.

Bilinskaya A, Goodlet KJ, Nailor MD. Evaluation of a best practice alert to reduce unnecessary Clostridium difficile testing following receipt of a laxative. Diagn Microbiol Infect Dis 2018 Apr 21. [Epub ahead of print]

Permpalung N, Mahoney MV, McCoy C, Atsawarungruangkit A, Gold HS, Levine JD, Wong MT, LaSalvia MT, Alonso CD. Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab. Leuk Lymphoma 2018. [Epub ahead of print]

Wiens J, Snyder GM, Finlayson S, Mahoney MV, Celi LA. Potential adverse effects of broad-spectrum antimicrobial exposure in the intensive care unit. Open Forum Infect Dis 2017;5(2).

Datta R, McManus D, Topal JE, Juthani-Mehta M. Long-acting lipoglycopeptides for gram-positive bacteremia at the end of life to facilitate hospice care: a report of 3 cases. Open Forum Infect Dis 2018;5(1).

Perreault S, McManus D, Lin T, Anderson A, Ruggero M, Topal JE. Optimization of voriconazole dosing utilizing a validated voriconazole dose modification guideline (VDMG) in hematologic patients. J Oncol Pharm Pract 2018 Jan 1.

Stover KR, Ballou J, Liles AM, Fleming LW, Fleming JW, Riche DM, Pitcock JJ, King ST, Capino A. Assessment of the landscape of clinical productivity tracking via reporting of quality patient indicators. J Am Coll Clin Pharm 2018;1-8. [Epub ahead of print]

Stover KR, King ST, Barber KE. Impact of an infectious diseases advanced pharmacy practice experience on student knowledge. Curr Pharm Teach Learn 2018;10(8). Online ahead of print June 2018.

Wingler MJB, Epperson TM, Stover KR, Wagner JL, Barber KE. Acute bacterial skin and skin structure infections (ABSSSI): new and emerging treatment options. MAD-ID Newsletter Continuing Education Article 2018;8:6-23.

Folan SA, Marx KR, Tverdek FP, Raad I, Mulanovich VE, Tarrand JJ, Shelburne SA, Aitken SL. Clinical outcomes associated with linezolid resistance in leukemia patients with linezolid-resistant Staphylococcus epidermidis bacteremia. Open Forum Infect Dis 2018;5.

White BP, Wagner JL, Barber KE, King ST, Stover KR. Risk factors for failure in complicated intra-abdominal infections. South Med J 2018;111:125-32.

Zembles TN, Mitchell ML, Huppler AR. The antimicrobial stewardship’s next frontier: solid organ transplantation. J Pharm Soc Wis 2018;21:26-8.

Zembles TN, Flannery L, Huppler A. Development and implementation of an antimicrobial lock guideline in a pediatric hospital. Am J Health Syst Pharm 2018;75:299-303.

Other Notable Achievements

Brandon Dionne:
Added Qualifications in Infectious Diseases (AQ-ID).
Selected for ACCP Mentored Research Investigator Training (MeRIT) Program.

Monica Mahoney: Secretary, Board for Massachusetts Society of Health-System Pharmacists (2018–2020).

Promotions

Rachel F. Eyler: Clinical Associate Professor, University of Connecticut School of Pharmacy.

Ayesha M. Khan: Clinical Associate Professor, Chicago State University College of Pharmacy.

Awards

Rachel F. Eyler: 2018 Teacher of the Year, University of Connecticut School of Pharmacy.

Calvin J. Meaney:
2018 Faculty Preceptor of the Year, University at Buffalo School of Pharmacy and Pharmaceutical Sciences.
2018 Teacher of the Year, University at Buffalo School of Pharmacy and Pharmaceutical Sciences.

Timothy Nguyen: 2018 Faculty Preceptor of the Year, LIU Pharmacy (Arnold & Marie Schwartz College of Pharmacy and Health Sciences).

Grants

Michelle Fravel: Fraternal Order of Eagles Grant: Assessing Barriers and Facilitators to Phosphate Binder Adherence in a Dialysis Population.

Publications

El Nekidy WS, Soong D, Kadri A, et al. Salvage of hemodialysis catheter in staphylococcal bacteremia: case series, revisiting the literature, and the role of the pharmacist. Case Rep Nephrol Dial 2018;8:121-9.

Books JM, Chapman CG, Suneja M, Schroeder MC, Fravel MA, et al. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for geriatric ischemic stroke patients: are the rates right? J Am Heart Assoc 2018;7:e009137.

Fusco NM, Meaney CJ, Wells C, Frederick CA, Prescott WA. Vancomycin versus vancomycin plus rifampin for the treatment of acute pulmonary exacerbations of cystic fibrosis. J Pediatr Pharmacol Ther 2018;23:125-31.

Fusco NM, Prescott WA, Meaney CJ. Pharmacokinetic monitoring of vancomycin in cystic fibrosis: is it time to move past trough concentrations? Pediatr Infect Dis J 2018. [Epub ahead of print]

Borghol A, Aucoin M, Onor I, Jamero D, Hawawini F. Modafinil for the improvement of patient outcomes following traumatic brain injury. Innov Clin Neurosci 2018;15:17-23.

Onor IO, Stirling DL, Williams SR, Bediako D, Borghol A, Harris MB, Darensburg TB, Clay SD, Okpechi SC, Sarpong DF. Clinical effects of cigarette smoking: epidemiologic impact and review of pharmacotherapy options. Int J Environ Res Public Health 2017;14:1147.

Ezebuenyi MC, Brakta F, Onor IO, Sarpong DF, Burks KB, Figueroa JE. Evaluation of physician prescribing patterns for antibiotics in the treatment of nonnecrotizing skin and soft tissue infections. P T 2018;43:287-92.

Sincerest congratulations to our recently elected Chair-Elect, Kat Walker, and Secretary-Treasurer, Nhi Tran! Kat and Nhi will begin their terms following the Global Conference Meeting in October.

Experts in Training Newsletter

We have an opportunity as a PRN to share more about ourselves and include a brief article in theresident and fellow newsletter that relates to current issues in our field. Our last article was regarding opioid stewardship and the one prior addressed opioid induced constipation. The PRN would love to open up this opportunity to a learner and facilitator/preceptor. Please email Stephanie Abel ([email protected])if you are interested.

Global Conference Meeting

The ACCP Global Conference in Seattle, WA is swiftly approaching (October 20 – 23).

Our PRN business meeting is Sunday the 21st from 6:30 – 8:30 pm in the Sheraton Seattle Hotel (conference hotel), second floor, Aspen room. Please let me know if you have an item you’d like to be considered for the agenda of this meeting. Additionally, if you cannot attend but would like a topic to be considered for next year’s focus session discussion, please email me. Congratulations to the following learners who were selected for the Pain and Palliative Care PRN travel awards and will be presenting at the business meeting:

Brittany Faley, PharmD Candidate 2019, University of Iowa College of Pharmacy. Brittany will be presenting on "Antimicrobial Stewardship in Palliative Care"

Krysta Walter, PharmD Candidate 2019, University of Michigan College of Pharmacy. Krysta will be presenting on "Medication Regimen Complexity in Palliative Care Patients"

Our PRN Focus Session, “Opioid Stewardship – A Quality Improvement Approach”, is on Tuesday the 23rd from 1:15 – 2:45 pm at the Washington State Conference Center, Level Three, Tahoma 1 & 2.

Comprehensive meeting information may be found by clicking here.

Several Pediatrics PRN subcommittees are developing new programming and opportunities for its members.
     The Pediatrics PRN Education Committee is organizing the resident/fellow journal clubs for next year. The journal clubs are open to any resident or fellow member of ACCP who would like the opportunity to present on a pediatric topic nationally. The journal clubs will be held at 3 p.m. (EST) on the below dates. Application deadlines are given below. Contact Samie Sabet for more information at [email protected].

Journal Club Date	Application Due Date
Oct 16, 2018	Aug 20, 2018
Jan 15, 2019	Nov 19, 2018
Apr 2, 2019	Feb 4, 2019

The Pediatrics PRN focus session at the 2018 ACCP Global Conference on Clinical Pharmacy in Seattle, Washington, will be held Monday, October 22, at 1:45 p.m. The 90-minute session, “Growing Pains: Pediatric Pain Management,” will feature three speakers discussing various aspects of acute and chronic pain management in pediatric patients. Please join the PRN membership for this session.
     The PRN is always looking for new team members. If you are interested in joining the PRN’s committee, please reach out to Samie Sabet ([email protected]) or Elizabeth Goswami ([email protected]).
     The Pediatrics PRN Research Committee continues to support PRN members in their research and scholarly endeavors. Committee members are also organizing pediatric poster rounds at the Global Conference.
     The Pediatrics PRN Travel Awards Committee will provide two awards again this year, one for students and one for residents.
     The Social Media Committee is sharing what is happening and coming up in the Pediatrics PRN through Facebook and Twitter as well as the PRN’s website. The PRN is also looking for ways to engage its members through spotlights and clinical pearls. One initiative to help with this involves selecting a resident member liaison for the committee. This position will give a resident the opportunity to take on a leadership role in the PRN as well as help the chair with the latest and greatest ways to share information through social media. The liaison will be announced in September 2018.
     The Nominations Committee, together with the ACCP staff, finalized the officer nomination and election process for 2018–2019. In addition, this will be the second year for the Pediatrics PRN awards; the PRN Achievement Award, given to an individual demonstrating leadership and a high level of contribution to pediatric practice and the PRN; and the Outstanding Practitioner Award, given to an individual showing innovative and excellence in providing clinical pediatric pharmacy services. Awardees will be selected by a panel of prior award winners and recognized at the 2018 Global Conference. The PRN looks forward to celebrating these achievements of its members.

Promotions

Peter D. Anderson: Lieutenant Colonel, Medical Service Corps, U.S. Army Reserve.

John Brock Harris: Associate Professor, Wingate University School of Pharmacy, Wingate, North Carolina.

Collin A. Hovinga: Senior Vice President, Institute for Advanced Clinical Trials in Children (I-ACT for Children).

Joseph LaRochelle: Clinical Professor of Pediatrics, Louisiana State University Health Sciences Center School of Medicine.

Joshua D. Robinson: Promoted from PGY2 Pediatric Critical Care Resident to Pediatric Clinical Pharmacist, Lucile Packard Children’s Hospital Stanford.

Awards

Omayma Kishk: 2017–2018 Preceptor of the Year, Maryland Health System Pharmacy.

Anne Thorndyke: Member-at-Large, ACCP Resident Advisory Committee.

Grants

John Brock Harris: Wingate University Board of Visitors Grant, Wingate University School of Pharmacy Summer Academy.

Collin A. Hovinga: I-ACT for Children Pediatric Trials Network (FDA Grant 5U18FD006297).

Publications

McCrory BE, Harper HN, McPhail GL. Use and adverse effects of proton pump inhibitors in patients with cystic fibrosis. Pharmacotherapy 2018;38:725-9.

Orth LE, O’Mara KL. Impact of early versus late diuretic exposure on metabolic bone disease and growth in premature neonates. J Pediatr Pharmacol Ther 2018;23:26-33.

Arends A, Pettit R. Safety of extended interval tobramycin in cystic fibrosis patients less than 6 years old. J Pediatr Pharmacol Ther 2018;23:152-8.

Kuti JL, Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP. Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations. Diagn Microbiol Infect Dis 2018;91:294-7.

Robinson JD, Moss JM, Yang QZ, Schwenk HT. Botulism immune globulin intravenous utilization evaluation in a children’s hospital. J Pediatr Pharmacol Ther. In press.

Shelton CM, Gray MD, Crill CM. To mist or not to mist: an update on the recommendations for live-attenuated influenza vaccine. J Am Pharm Assoc 2018;58:457-9.

Russell GR, Phelps SJ, Shelton CM, Wheless JW. Impact of drug interactions on clobazam and N-desmethylclobazam concentrations in pediatric patients with epilepsy. Ther Drug Monitor 2018 May 4. [Epub ahead of print]

Williams JS, Metcalfe A, Shelton CM, Spivey CA. Examination of the association of GPA and PCAT scores on objective structured clinical examination scores. Am J Pharm Educ. [Epub ahead of print]

Smith KP, Madison CM. Transgender patients. In: Women’s and Men’s Care I, Ambulatory Care Self-Assessment Program (ACSAP), 2016–2018. Lenexa, KS: American College of Clinical Pharmacy, 2018.

New ACCP Fellows

Alison B. Blackmer

John Brock Harris

Chasity M. Shelton

Other Notable Achievements

Collin A. Hovinga:
Appointed to the Advisory Committee for Connect for Children – European pediatric organization funded by IMI 2 (No. 777389) and EU Horizon 2020 research and innovation program.
Appointed as the Head of Scientific Advisory Committee of the FireFly Fund – nonprofit set up to research treatments for NPC1.

Chasity M. Shelton: Selected to participate in the AACP Academic Leadership Fellows Program in Cohort 15 for the 2018–2019 academic year.

Katherine P. Smith: Obtained Graduate Certificate in LGBT Health Policy & Practice from George Washington University, Washington, D.C., May 15, 2018.

Thank you to all presenters and attendees of the Perioperative Care PRN’s 2018 webinar series. The PRN wishes to thank Drs. Sara Jordan, Eric Johnson, Rachel Wolfe, and Jenna Lovely for leading interesting and informative webinars during 2018.

Perioperative Care Focus Session – The OR Blues: Management of Perioperative Emergencies

The Education Committee, led by Chair-Elect Marian Gaviola, has organized an exciting and interesting focus session for the 2018 ACCP Global Conference on Clinical Pharmacy in Seattle, Washington. Drs. Mitchell Daley, Christopher Adams, and Gourang Patel have been confirmed to speak on the following titles: (1) “Massive Transfusion, More Than Just Blood: A Focus on Pharmacologic Adjuncts”; (2) “Malignant Hyperthermia – One Hot Topic”; and (3) “Slow to Wake: Managing Delayed Emergence in the Postsurgical Setting.”

Position Paper on Enhanced Recovery After Surgery (ERAS)

In conjunction with ERAS Society leaders, Drs. Olle Ljungqvist and Greg Nelson, the presenters of last year’s focus session on enhanced recovery, have submitted a position paper to be considered as a PRN opinion.

Perioperative Care App for iPhone and Android

Interested members are asked to sign up for developing an app for perioperative care pharmacotherapy. This task force (6-month commitment beginning at the Global Conference) will (1) identify the scope of a potential app for the iPhone and the Android, (2) determine the app’s functionality for perioperative care practice (concentrating on pharmacotherapy), and (3) identify potential markets for app distribution. PRN leadership will work with ACCP staff to develop a marketing plan and sales collateral for the app’s release.

Awards

Birrer KN:
Preceptor of the Year 2017–2018.
Orlando Regional Medical Center Pharmacy Residency Program Leadership Award for Excellence.
Neurocritical Care Society’s Travel Grant Award for the 16th Annual Meeting.

Publications

Curry D, Birrer KL, Carothers C. Comparison of intracranial pressure reduction between 7.5% and 23.4% hypertonic saline. Neurocrit Care 2018;29(suppl 1). (Pending publication, abstract accepted for presentation at 2018 NCS meeting and will be in this supplement)

Parrish RH II:
Current trends and emerging priorities in compounded preparations for children. Int J Pharm Compound 2018. Fall feature. In press.
Roundtable 1 – formulary operation: nuts and bolts. Pharmacy (Basel) (Special Issue – Proceedings of the Singapore National Clinical Pharmacy Colloquium – Health Manpower Development Planning) 2018. In press.
Lecture 2 –what is a formulary, anyway? (Or the Cliff Notes version of drug stewardship and expense control). Pharmacy (Basel) (Special Issue – Proceedings of the Singapore National Clinical Pharmacy Colloquium – Health Manpower Development Planning) 2018;6:69.
Lecture 2 – what is a formulary, anyway? Part 2. Pharmacy (Basel) (Special Issue – Proceedings of the Singapore National Clinical Pharmacy Colloquium – Health Manpower Development Planning) 2018;6:72.
Lecture 3 – measuring pharmacy’s work in the 21st century. Pharmacy (Basel) (Special Issue – Proceedings of the Singapore National Clinical Pharmacy Colloquium – Health Manpower Development Planning) 2018;6:63.

Parrish RH II, Chew L. Lecture 1 – justification of the value of clinical pharmacy services and clinical indicators measurements – introductory remarks from a traveler on a 40-year wayfaring journey with clinical pharmacy and pharmaceutical care. Pharmacy (Basel) (Special Issue – Proceedings of the Singapore National Clinical Pharmacy Colloquium – Health Manpower Development Planning) 2018;6:56.

Parrish RH II, Chew L. Briefing note. Pharmacy (Basel) (Special Issue –Proceedings of the Singapore National Clinical Pharmacy Colloquium – Health Manpower Development Planning) 2018;6:54.

Smith AN. Neurohormonal influences on obesity. Bariatric Times 2017;14:10-4.

Smith AN. Nutritional considerations in the bariatric surgery patient. In: Murphy JE, Lee MW, eds. Ambulatory Care Self-Assessment Program, 2017. Nutritional/Gastroenterologic Care. Lenexa, KS: American College of Clinical Pharmacy, 2017.

Ramsdell T, Smith AN, Kerkhove, E. Compliance with updated sepsis bundles to meet new sepsis core measure in a tertiary care hospital. Hosp Pharm 2017;52:177-86.

Presentations

Parrish RH II:
Implementing ENERGY techniques into your practice. Invited podium presentation at: ASMBS Weekend; June 15, 2018; New York, NY.
How does the pharmacist fit in to ERAS? Invited podium presentation at: 18th Annual Minimally Invasive Surgery Symposium; March 7, 2018; Las Vegas, NV.
Opioid crisis in America: can ERAS help? Invited podium presentation at: 18th Annual Minimally Invasive Surgery Symposium; March 6, 2018; Las Vegas, NV.
Pharmacist’s role on the bariatric surgery team. Invited faculty for webinar sponsored by: Greater New York Health Association. 1.0 hour CE webinar given November 21, 2017.
Clinical practice hot topics in bariatric surgery & pharmacology. Integrated Health Pharmacology Course: Obesity Week 2017; October 30, 2017; Washington, DC.

Other Notable Achievements

Richard H. Parrish II and John van der Anker will coedit a special issue in the international online peer-reviewed journal, Children. The topic for the special issue will tentatively be titled “A National Pharmacotherapy Collaborative Practice Network for Children.” This issue will (1) address the need for development of a national pharmacotherapy collaborative practice network focused primarily on ambulatory and transitions of care; (2) assess and suggest subspecialty practice needs within pharmacotherapy and clinical pharmacy; and (3) integrate complementary and alternative medicine pediatricians and their patients into an evolving medication safety net for system-level medication needs assessment, formulation, and research. Authors interesting in submitting manuscripts for consideration can contact Richard Parrish at [email protected] for more information. The submission deadline is March 31, 2019.

April N. Smith: Elected to the Integrated Health Executive Committee of the American Society for Metabolic and Bariatric Surgery.

On April 17, the Pharmaceutical Industry PRN hosted a career panel for interested students to learn about the different paths to and within the pharmaceutical industry. Panelists included Margaret Noyes Essex, Pharm.D., FCCP; Maria Sheridan, Pharm.D., BCNSP; Suzanne Soliman, Pharm.D., BCMAS; Kathy Goldstein, Pharm.D., CCRA; and Carmelina Tyler, Pharm.D., BCPS.

The PK/PD/PG PRN has been spearheading a multi-PRN opinion paper on the application of precision medicine across pharmacy specialty areas. Kelly Caudle, Pharm.D., Ph.D., current PK/PD/PG PRN chair, has been leading this initiative and coordinating the efforts of members from 18 PRNs. The PRN is also excited to present its joint PRN focus session with the Geriatrics PRN at the 2018 ACCP Global Conference on Clinical Pharmacy in Seattle, Washington, titled “Impact of Aging on PK/PD/PG Parameters in Older Adults.” This event will be held Sunday, October 21, from 4:00 p.m. to 5:30 p.m. (PDT). In addition, the PRN welcomes everyone to join its members for dinner and drinks at the PRN’s annual business meeting and networking forum on Monday, October 22, at 6:30 p.m.

Promotions

David Gregornik: Pharmacogenomics Program Director, Children’s Minnesota, Minneapolis, Minnesota.

Awards

Cyrine-Eliana Haidar: 2018 ACCP Clinical Practice Award.

Jasmine Luzum: Finalist for the Jay N. Cohn New Investigator Award from the Heart Failure Society of America.

Grants

Ryan Funk:
Co-Investigator: Trimethoprim: An Overlooked Contributor of Trimethoprim-Sulfamethoxazole Idiosyncratic Adverse Drug Reactions. NIGMS R01 (PA-16-160) (July 1, 2018 – June 30, 2023).
Principal Investigator: Metabolomic Markers of Methotrexate Response in Autoimmune Arthritis. Frontiers: The Heartland Institute for Clinical and Translational Research KL2 Career Development Award (November 6, 2017 – June 30, 2019).
Principal Investigator: A Biochemical Strategy to Mitigate Methotrexate Toxicity in Patients with Down Syndrome. PhRMA Foundation Pharmacology/Toxicology Research Starter Grant (January 1, 2018 – December 31, 2018).

Jasmine Luzum: Pilot Grant from the Michigan Institute for Clinical and Health Research (MICHR) to study genetic variants associated with recovery from chemotherapy-induced cardiomyopathy.

Publications

Brown JT, Gregornik DS, Kennedy MJ. Pediatric Pharmacy Advocacy Group position statement on pharmacogenomics in pediatrics. J Pediatr Pharmacol Ther 2018. In press.

Olander M, Waring S, Stenehjem DD, Taran A, Ranelli PL, Brown JT. Primary care clinicians attitudes and knowledge of pharmacogenetics in a large, multi-state, healthcare system. Innov Pharm 2018;9:Article 6.

Caudle KE, Keeling NJ, Klein TE, Whirl-Carrillo M, Pratt VM, Hoffman JM. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward. Pharmacogenomics 2018;19:847-60.

Whaley SG, Zhang Q, Caudle KE, Rogers PD. Relative contribution of the ABC transporters Cdr1, Pdh1, and Snq2 to azole resistance in Candida glabrata. Antimicrob Agents Chemother 2018 Jul 23. [Epub ahead of print]

Lynn H, Sun X, Ayshiev D, Siegler JH, Rizzo AN, Karnes JH, Gonzales-Garay M, Casanova N, Camp SM, Wang T, Ellis NA, Garcia JGN. Single nucleotide polymorphisms (SNPs) in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans. PLoS One 2018. In press.

Mosley JD, Feng Q, Wells QS, Van Driest SL, Shaffer CM, Edwards TL, Bastarache L, Wei WQ, Davis LK, McCarty CA, Thompson W, Chute CG, Jarvik GP, Gordon AS, Palmer MR, Crosslin DR, Larson EB, Carrell DS, Kullo IJ, Pacheco JA, Peissig PL, Brilliant MH, Linneman JG, Namjou B, Williams MS, Ritchie MD, Borthwick KM, Verma SS, Karnes JH, Weiss ST, Wang TG, Stein CM, Denny JC, Roden DM. A study paradigm to integrate prospective epidemiologic cohorts and electronic health records to identify new disease biomarkers. Nat Commun 2018. In press.

Lamprecht DG Jr, Shaw PB, King JB, Hogan KN, Olson KL. Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service. J Clin Lipidol 2018;12:999-1007.

Luzum JA, Peterson E, Li J, She R, Gui H, Liu B, Spertus JA, Pinto YM, Williams LK, Sabbah HN, Lanfear DE. Race and beta-blocker survival benefit in patients with heart failure: an investigation of self-reported race and proportion of African genetic ancestry. J Am Heart Assoc 2018;7.

Kashuba A, Schwartz JL, Doncel GF. Differences in local and systemic TFV PK among premenopausal versus postmenopausal women exposed to TFV 1% vaginal gel. J Acquir Immune Defic Syndr 2018;78:82-92.

Eke AC, Chakhtoura N, Kashuba A, Best BM, Sykes C, Wang J, Stek AM, Smith E, Calabrese S, Capparelli EV, Mirochnick M, IMPAACT P1026s Protocol Team. Rilpivirine plasma and cervicovaginal concentrations in women during pregnancy and postpartum. J Acquir Immune Defic Syndr 2018;78:308-13.

Mavigner M, Habib J, Deleage C, Rosen E, Mattingly C, Bricker K, Kashuba A, Amblard F, Schinazi RF, Jean S, Cohen J, McGary C, Paiardini M, Wood MP, Sodora DL, Silvestri G, Estes J, Chahroudi A. SIV persistence in cellular and anatomic reservoirs in ART-suppressed infant rhesus macaques. J Virol 2018. [Epub ahead of print]

Brocca-Cofano E, Xu C, Wetzel KS, Cottrell ML, Policicchio BB, Raehtz KD, Ma D, Dunsmore T, Haret-Richter GS, Musaitif K, Keele BF, Kashuba AD, Collman RG, Pandrea I, Apetrei C. Marginal effects of systemic CCR5 blockade with maraviroc on oral simian immunodeficiency virus transmission to infant macaques. J Virol 2018. [Epub ahead of print]

McKinnon LR, Liebenberg LJ, Yende-Zuma N, Archary D, Ngcapu S, Sivro A, Nagelkerke N, Garci Lerma JG, Kashuba AD, Masson L, Mansoor LE, Karim QA, Karim SSA, Passmore JS. Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women. Nat Med 2018;24:491-6.

Weber MD, Andrews E, Prince HA, Sykes C, Rosen EP, Bay C, Shaheen NJ, Madanick RD, Dellon ES, De Paris K, Nelson JA, Gay CL, Kashuba AD. Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and women. Antivir Ther 2018. [Epub ahead of print]

Schauer AP, Sykes C, Cottrell ML, Prince H, Kashuba ADM. Validation of an LC-MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots. J Pharm Biomed Anal 2018;149:40-5.

Srinivas N, Maffuid K, Kashuba ADM. Clinical pharmacokinetics and pharmacodynamics of drugs in the central nervous system. Clin Pharmacokinet 2018;57:1059-74.

Thurman AR, Chandra N, Yousefieh N, Kimble T, Anderson SM, Cottrell M, Sykes C, Nicol MR, Brewers LM, Kashuba ADM, Sykes C. The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue. AIDS 2018;32:11-5.

Other Notable Achievements

Varsha Bhatt-Mehta: Appointed as Deputy Editor of AAPSOpen, the official open access international journal of the American Association of Pharmaceutical Sciences (AAPS).

Emily Schwartz: Completed fellowship at the University of Florida and started new position as Clinical Assistant Professor with the University of Florida, College of Pharmacy, Department of Pharmacotherapy and Translational Research.

Awards

Jennifer Austin Szwak: 2018 University of Chicago Choosing Wisely Challenge Winner for “Nebs No More After 24.”

Grants

Jennifer Austin Szwak: 2018 University of Chicago Innovations Grant recipient (with an interdisciplinary team) for “ACT VALUE Program for Asthma and COPD” (Ambulatory Care Transformation Using Value-Based Assessment and Learning for Under-recognized Etiologies: Asthma & COPD).

Publications

Wilken L, Eades A. Asthma. In: Chisholm-Burns MA, et al., eds. Pharmacotherapy Principles & Practice, 5th ed. New York: McGraw-Hill. In press.

Gregory KL, Wilken L, Hart MK. Guide to Aerosol Delivery Devices for Physicians, Nurses, Pharmacists and Other Health Care Professionals, 3rd ed. American Association for Respiratory Care, January 5, 2018.

Wilken LA, Joo MJ. Pulmonary function and related tests. In: Lee M, ed. Basic Skills in Interpreting Laboratory Data, 6th ed. Bethesda, MD: American Society of Health-System Pharmacists, 2017:315-27.

Other Notable Achievements

Laura Traynor: Asthma Educator – Certified 2018.

Lori A. Wilken:
Board Certified Ambulatory Care Pharmacist, Board of Pharmacy Specialties, Certificate 6110488.
Asthma Educator – Certified, June 2004 – July 2025, National Asthma Educator Certification Boards, Certificate 822.
National Certificate in Tobacco Treatment Practice, June 13, 2018, Association for Addiction Professionals and Association for the Treatment of Tobacco Use and Dependence.

Richard Williams: Associate Director of Pharmacy, SUNY Downstate Medical Center.

Introduction

This was another exciting and productive season for the Women’s Health PRN. Members’ publications, awards, accomplishments, and grants are listed below.

Promotions

Shareen El-Ibiary: Department Chair, Department of Pharmacy Practice, Midwestern University College of Pharmacy-Glendale.

John Brock Harris: Associate Professor at Wingate University School of Pharmacy, Wingate, North Carolina.

Angela K. Nagel: Vice Chair, Department of Pharmacy Practice and Administration; Wegmans School of Pharmacy, St. John Fisher College.

Patricia Wigle: Professor, Clinical Pharmacy Practice Division of Pharmacy Practice University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, Ohio.

Awards

Zaneera Hassan: Nellie Wakeman Fellowship 2018–2019. $7500 awarded February 2018, sponsored by the American Foundation for Pharmaceutical Education and Kappa Epsilon Pharmacy Fraternity.

Mary Beth O’Connell: Lambda Kappa Sigma Professional Pharmacy Fraternity Advisor of the Year Award.

Grants

Angela K. Nagel: 2018 Faculty Research Awards Program (FRAP). Funding by Wegmans School of Pharmacy, St. John Fisher College.

Sally Rafie:
Principal Investigator: Community Grant from March of Dimes. Project title: “Healthy Pregnancies and Healthy Babies: Pharmacist Interventions for Improved Outcomes.”
Co-Principal Investigator: Community Engagement Grant from University of California San Diego Altman Clinical & Translational Research Institute. Project title: “Exploring the Layers of Logistics for Adoption: Utilizing the PRISM Framework-Informed Implementation Intervention for Direct Provision of Emergency Contraception by Pharmacists (ELLA Study).”

Publications

Dickson B, Mansfield C, Guiahi M, Allhouse AA, Borgelt L, Sheeder J, Silver RM, Metz TD. Recommendations from cannabis dispensaries about first trimester cannabis use. Obstet Gynecol 2018;131:1031-8.

Anderson L, Borgelt LM, Clark P, Moore G. Encouraging comprehensive and consistent pharmacist education for provision of contraception. J Am Pharm Assoc 2018;58:113-6.

Crume TL, Juhl AL, Brooks-Russell A, Hall KE, Wymore E, Borgelt LM. Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. J Pediatr 2018;197:90-6.

DeSalvo K, Stamm C, Borgelt LM. Evaluation of reported contents in prescription and over-the-counter prenatal multivitamins. J Am Pharm Assoc 2018;58:258-267.e3.

Traynor AP, Borgelt LM, Rodriguez T, Ross LA, Schwinghammer T. Use of a modified Delphi process to define the leadership characteristics expected of pharmacy faculty. Am J Pharm Educ 2018. In press.

Fortuna R, Nagel A, Rocco T, Legette-Sobers S, Quigley D. Patient experience with care and its association with adherence to hypertension medications. Am J Hypertens 2018;31:340-5.

Ng C, Rafie S, Najjar R, DiPietro Mager N. Pharmacist and student pharmacist perspectives on providing preconception care in the United States. J Am Pharm Assoc 2018;58:426-31.

Raifman S, Orlando M, Rafie S, Grossman D. Medication abortion: potential for improved access through pharmacies. J Am Pharm Assoc 2018;58:377-81.

Stone RH, Anguiano R, Falk K, Bobowski C, Alvarez P, Mastrogiannis D. Latency of 17OHP delivery from prescription to first dose in patients receiving compound vs commercial product and patient outcomes. J Reprod Med 2018;63:276-84.

New ACCP Fellows:

Patricia Wigle

Other Notable Achievements

Mary Beth O’Connell: Fellow, American Geriatrics Society.